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ABSTRACT
TRANSCRIPTIONAL ELONGATION DEFECTS ENHANCE UPSTREAM POLY (A) 
SITE UTILIZATION AND SPT5 AFFECTS mRNA DEGRADATION THROUGH ITS 
PHYSICAL AND FUNCTIONAL INTERACTION WITH CCR4-NOT COMPLEX
by 
Yajun Cui
University of New Hampshire, May 2003
While a number of proteins are involved in elongational processes, the 
mechanism of action o f most o f these factors remains unclear primarily because o f the 
lack o f suitable in vivo model systems. We have identified in yeast several genes, each 
o f which contain internal poly (A) sites, whose full-length mRNA formation is reduced 
by mutations in RNA polymerase II subunit RPB2, elongation factor SPT5, or TFIIS. 
RPB2 and SPT5 defects also promoted the utilization of upstream poly (A) sites foT genes 
that contain multiple 3’ poly (A) signaling sequences, supporting a role for elongation in 
differential poly (A) site choice. Our data suggest that elongation defects cause increased 
transcriptional pausing or arrest that results in increased utilization of internal or 
upstream poly (A) sites. Transcriptional pausing/arrest can, therefore, be visualized in 
vivo if  a gene contains internal poly (A) sites, allowing biochemical and genetic study of 
the elongation process.
The CCR4-NOT complex has been shown to have role in transcriptional 
initiation, elongation, and mRNA degradation with the primary role o f CCR4 and CAF1 
in the deadenylation and degradation of mRNA. Previous work in our lab has identified a
viii
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physical connection between the CCR4-NOT complex and SPT5. The role of SPT5 in 
mRNA degradation was examined. Mutation in SPT5 or an spt4 deletion slowed the rate 
of mRNA degradation, a phenotype associated with defects in the CCR4 and CAF1 
mRNA deadenylase complex. Moreover, like ccr4 and cafl deletion, spt5 and spt4 
defects affected the rate of deadenylation, but not that of decapping or 5’-3’ degradation 
of mRNA. Re-examination of SPT5 location in the yeast cell confirmed that SPT5 is 
primarily nuclear but some SPT5 was also found to locate to the cytoplasm. These results 
support a role for SPT5/SPT4 in mRNA degradation through inhibition of CCR4 
deadenylase activity.
ix
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GENERAL INTRODUCTION
Gene expression is a complex biochemical process that is governed by the 
concerted action of a diverse collection o f regulatory factors. These process can be 
divided into synthesis of pre-mature mRNA, modification of pre-mRNA, export of 
mature mRNA from the nucleus to the cytoplasm, translation of mRNA into protein and, 
finally, degradation of mRNA. At this time, many genome sequencing projects have been 
completed and the number of genes for several organisms have been quantitated. E.coli, 
for instance, has more than 5000 genes; Yeast has more than 6000 genes. Drosophila has 
about 13,500 genes and our human cells are estimated to contain about 30,000 genes. The 
response of cells to physiological and environmental stimuli requires tight regulation of 
their gene expression, for the multicellular organism, the remarkable diversity in cell 
specialization is achieved by precisely controlling when and to what extent genes are 
expressed. In humans, many diseases result from mutations that affect various aspects of 
mRNA metabolism, including pre-mRNA processing, export, stability, and translational 
control. Understanding how gene expression is regulated is therefore very important to 
comprehending biological processes.
The Regulation of Gene Transcription
The first step of gene expression is the synthesis of mRNA, a process termed 
transcription. Most eucaryotic genes are transcribed by RNA polymerase II (RNA pol II), 
also known as RNA polymerase B (RPB). Yeast RNA pol II is composed of 12 subunits
1
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encoded by the RPB1 to RPB12 genes (Kolodziej et al., 1990). The two largest RNA pol 
II subunits, RPB1 (-200 kDa) and RPB2 (-150 kDa), are the most highly conserved 
subunits o f this complex and encode proteins that are orthologs of bacterial RNA 
polymerases.
The first event of transcription is the binding of RNA pol II to the promoter 
region of a gene. Eucaryotic promoters include two independent regulatory DNA 
sequences, named core elements and regulatory elements. Core elements define the site 
for recruiting RNA pol II and some general transcription factors. Regulatory elements are 
gene-specific sequences that are located upstream of the core promoter and control the 
rate o f transcription initiation. General transcription factors, including TBP, TFI03, 
TFDE, TFEDF, and TFIIH, are required for RNA pol II to bind to core promoter elements 
and initiate transcription accurately (Roeder, 1996). The first transcription factor to 
associate with the promoter region during transcription initiation is TBP which 
recognizes the TATA element in the core promoter. After TBP and its associated factors 
bind, TFDOB will associate with TBP to stabilize the TATA-TBP interaction and recruit 
RNA pol II and other general transcription factors (Orphanides et al., 1996; Roeder, 
1996).
Many factors play roles in the regulation of transcription initiation. Some proteins 
can directly bind to the DNA regulatory elements to control the rate of transcription 
initiation. Other proteins regulate initiation positively or negatively by interaction either 
with general transcription factors (TFIIA, TBP-Associated Factors (TAFs), CCR4/NOT 
etc..) or with nucleosomes (SWI/SNF, Histone Acetyltransferase (HAT), SPT5/SPT4 
etc.).
2
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Following transcription initiation, RNA pol II moves away from the promoter 
region and dissociates from some of the general transcription factors after synthesizing a 
10 to 15 nucleotide-long transcript. This is called promoter escape. Biochemical studies 
have shown that during early elongation and promoter escape the transcripts less than 
approximately 9 nucleotide-long are unstable and RNA polymerase is prone to aborting 
transcription (Holstege et al., 1997; Keene and Luse, 1999). Transcription factor TFIIF 
can decrease the frequency of abortive transcription, and TFEDE and TFIIH can also help 
RNA pol II to overcome some transcription difficulties during promoter escape (Dvir et 
al., 1997; Kugel and Goodrich, 1998; Kumar et al., 1998; Yan et al., 1999). After RNA 
pol II leaves the promoter region, mRNA will continue to be synthesized along the DNA 
template. This step is called elongation. During transcriptional elongation, addition of the 
next nucleotide to a growing RNA chain by RNA pol II requires that the 3’-OH terminus 
o f the nascent transcript be precisely aligned with the DNA template and with the 
catalytic site of pol II for nucleotide addition. Pausing can occur when RNA pol II 
undergoes modest and reversible backsliding on the DNA template. RNA pol n  retains 
the ability to restart synthesis without the aid of additional factors. Arrest occurs with 
essentially irreversible backsliding of the RNA pol n. Ancillary factors are required to 
release RNA pol II from arrest, one of which is elongation factor IIS that enables pol II to 
be reactivated from transcriptional arrest by activation of nascent RNA cleavage (Wind 
and Reines, 2000).
Recently, a number of factors have been identified as either components of the 
elongating polymerase or as possible modulators of the process of elongation. For 
instance, DSDF and its yeast orthologs SPT4 and SPT5 possibly regulate elongation
3
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through interactions with hypophosphorylated RNA polymerase (Hartzog et al., 1998; 
Wada et al., 1998b; Wada et al., 1998c; Yamaguchi et al., 1999a). RPB1, -2, -5, -6 and -9  
are components of the RNA polymerase II enzyme and make contact with the DNA that 
would be important to the elongation process (Cramer et al., 2000; Hemming et al., 2000; 
Powell and Reines, 1996). In addition, a vast amount of genetic evidence has implicated 
these and other factors such as the recombination important protein HPR1 (Chavez and 
Aguilera, 1997; Chavez et al., 2001) and components of the CCR4-NOT complex (Denis 
et al., 2001) in controlling elongation.
The last phase o f transcription is termination/3’ end formation. Upon reaching the 
relatively ill-defined termination signals at the end of a gene, the nascent RNA is cleaved 
and the poly (A) tail is added to the 3’ end of RNA. The RNA transcript is released from 
RNA pol II and RNA pol II is dissociated from the DNA template. Sequence elements in 
the 3’ untranslated region (3’-UTR) of pre-mRNAs specify the site at which adenosines 
are added (termed poly (A) site). The mammalian 3’-end formation complex selects the 
poly (A) sites through recognition of the conserved upstream AAUAAA sequence and a 
degenerate downstream element. In contrast to higher eukaryotes, the yeast 
Saccharomyces cerevisiae uses degenerate and complex signals to direct the 3’-end 
formation. At least three elements are needed to make up a minimal yeast mRNA 3’-end: 
the UA-rich efficiency element; the A-rich positioning that directs the position of the 
cleavage site; and the actual site of polyadenylation (Zhao et al., 1999). RNA pol II 
transcription termination, in contrast, is a somewhat random process occurring at sites 
between 200-2000 bp downstream of the poly (A) site, although it is dependent upon the 
presence of a functional poly (A) signal (Proudfoot, 1989). On the other hand,
4
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transcriptional pause sites located downstream of the poly (A) site are thought to cause a 
transient pause to Pol II progression and so enhance poly (A) site recognition (Aranda 
and Proudfoot, 1999; Birse et al., 1997; Yonaha and Proudfoot, 1999; Yonaha and 
Proudfoot, 2000).
The Regulation of mRNA Degradation
The stability of mRNA is also an important determinant in gene expression. 
Regulation of the rate of mRNA degradation is a major factor in determining the 
abundance of cellular mRNA. In eucaryotic cells, the decay rates of individual mRNAs 
vary by more than two orders o f magnitude. Moreover, there are numerous examples of 
mRNA decay rates being regulated in response to various stimuli.
The mature mRNA bears a 5’ cap structure and 3’ poly (A) tail, both o f which 
protect the mRNA from degradation. Recent work has demonstrated that at least four 
related, yet distinct, pathways allow polyadenylated mRNAs to be degraded in eucaryotic 
cells (Beelman and Parker, 1995). In most cases the degradation of the transcript begins 
with the shortening of the poly (A) tail at the 3' end of the mRNA. A principal mRNA- 
degradation pathway is initiated by deadenylation (shortening of the poly (A) tail at the 
3’-end of mRNA), which is followed by decapping (removal of the 5’ cap structure). The 
rest o f mRNA is then digested 5’ to 3’ by exonucleases.
Many o f the components required for RNA 3'-end processing have now been 
identified and appear to be conserved between yeast and mammals. In yeast, a poly (A)- 
specific ribonucleases (PAN) was identified based on its requirement for the poly (A) 
binding protein (PAB1) for activity (Lowell et al., 1992; Sachs and Deardorff, 1992).
5
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PAN is composed of at least two subunits, PAN2 and PAN3, and is the first deadenylase 
for which the genes encoding the enzymatic activity have been identified (Boeck et al., 
1996; Brown et al., 1996). Recently, the CCR4-NOT complex has been identified as the 
major cytoplasmic deadenylase complex (Chen et al., 2002; Daugeron et al., 2001; 
Tucker et al., 2002; Tucker et al., 2001). It is suggested that PAN2/PAN3 exonuclease 
may play a role in initial trimming of the nuclear poly (A) tail (Brown and Sachs, 1998). 
After the nascent poly (A) tail o f the mRNA is trimmed by the PAN2/PAN3 nuclease, it 
is subsequently passed to the CCR4-NOT complex for the majority o f cytoplasmic 
deadenylation (Tucker et al., 2001).
The second step of mRNA degradation is decapping. Genetic and biochemical 
studies have shown that the DCP1 protein is the major mRNA decapping enzyme in yeast 
(Beelman et al., 1996). Several experiments suggest possible ways in which the activity 
o f the decapping enzyme maybe modulated. First, DCP1 can be posttranslationally 
modified, which will influence its activity. Second, the polypeptide DCP2 has been 
identified as a positive regulator o f the decapping enzyme and suggests that a direct or 
indirect interaction of DCP1 with DCP2 is required for production of active decapping 
enzyme (Dunckley and Parker, 1999). Finally, the protein chaperone HSP70 may 
function as a global regulator of DCP1 activity (Zhang et al., 1999).
The requirement of deadenylation before decapping indicates that the poly (A) tail 
also acts as an inhibitor of decapping(Decker and Parker, 1993; Muhlrad et al., 1994; 
Muhlrad et al., 1995). Several observations imply that the ability of the poly (A) tail to 
inhibit decapping is mediated through the poly (A) binding protein (PABl) (Caponigro 
and Parker, 1995; Morrissey et al., 1999; Sachs et al., 1987). One model is that the
6
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process of deadenylation can lead to a loss of PABl binding at the 3' end of the mRNA 
and the subsequent activation of decapping.
Cleavage of capped mRNAs by DCP1 yields the products m7GDP and a 5'- 
monophosphate mRNA. Production of a transcript with a 5'-monophosphate mRNA is 
functionally significant resulting in the rapid degradation by the 5' to 3' exonuclease 
Xmlp, which degrades mRNA following decapping.
The regulation of gene expression can also happen during pre-mRNA processing, 
mRNA transport from nucleus to cytoplasm, and the processes by which information is 
transferred from RNA to protein (translation). My project involved understanding how 
gene transcription and mRNA degradation are regulated, especially in the identification 
o f factors and mechanisms utilized in the control of eucaryotic transcriptional elongation 
and mRNA deadenylation.
I: Investigate the Role of Elongation Factors in Transcriptional Elongation in vivo
Recently, in yeast and other organisms, a number of factors have been identified 
as either components of the elongation polymerase or as possible modulators of the 
process of elongation. Biochemical and in vitro studies have demonstrated or suggested a 
requirement for several of these factors in elongation such as RPB2, SPT5/SPT4, HPR1, 
and TFHS.
During the process of elongation, RNA pol II can encounter a variety of 
transcriptional blocks including DNA sequences, DNA bound proteins, DNA binding 
drugs, and covalent modifications due to DNA damage. As a result of the RNA pol II 
structure being recently determined, it is clear that RPB2 may play multiple roles during
7
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elongation (Cramer et al., 2000). For instance, N-terminal regions of RPB1, RPB6, and 
C-terminal regions of RPB2 can form a clamp that can be used to bind the DNA templete 
near the active site during elongation. RPB1 and RPB2 can also form a funnel for 
substrate entry, backtracking, and elongation factor access. In vitro evidence confirms a 
key role for RPB2 in elongation. Mutations in the RPB2 gene result in sensitivity to the 
drug 6-azauracil (6AU), which reduces intracellular NTP concentrations and thus is 
expected to decrease the rate o f transcript elongation. RPB2 mutations also increase 
transcriptional arrest at known mammalian pause sites in vitro (Powell and Reines, 1996). 
In particular, the mutation in region H of RPB2 (rpb2-10), a domain highly conserved 
among all organisms that is associated with nucleotide binding (Scafe et al., 1990), has 
the most severe effect in elongation. Moreover, TFIIS is also required by RNA pol II to 
overcome the arrest in elongation that occurs at such sites in vitro (Powell and Reines, 
1996) and the rpb2-10 allele in combination with a dstl (encode TFIIS) deletion cause 
severe defects in the synthesis of most mRNA in vivo (Lennon et al., 1998), indicating 
that in vivo rpb2-10 is actually causing pausing/arrest of RNA pol II during elongation 
that requires TFIIS to suppress and overcome.
Suppressor of Ty (SPT) genes were originally identified through a genetic screen 
for mutations in the yeast Saccharomyces cerevisiae that restore gene expression 
disrupted by the insertion of the transposon Ty (Malone et al., 1993; Swanson et al., 
1991b; Winston and Carlson, 1992; Winston et al., 1984). The SPT genes have been 
identified as encoding either histones or proteins that affect chromatin function (Winston, 
1992). SPT4 and SPT5, as members of SPT class of genes, were implicated in 
transcriptional regulation by affecting chromatin function (Swanson and Winston, 1992).
8
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SPT4 and SPT5 form a complex in yeast and their higher eucaryotic orthologs are 
components of the DSIF complex. DSIF and SPT5/SPT4 have been found to be capable 
o f both stimulating and repressing pol II elongation. DSIF complex is known to be 
important to repressing elongation in vitro and appears to do so by acting together with 
negative elongation factor (NELF) and positive transcription elongation factor (P-TEF) b 
to regulate the phosphorylation of the C-terminal domain (CTD) of the pol II largest 
subunit (Wada et al., 1998b; Wada et al., 1998c; Yamaguchi et al., 1999a; Yamaguchi et 
al., 1999c). Studies on HIV transcription have revealed the possible mechanism 
underlying the stimulatory activity of DSIF. Successful transcription from the HIV LTR 
promoter requires the viral transactivator TAT. The absence of TAT results in a strong 
block to elongation at around +50 nt from the transcriptional start site. The SPT5 subunit 
o f DSIF has been identified as one of the factors that are required for Tat-dependent 
transcription and depleting SPT5 in a TAT dependent system promotes pausing and 
transcriptional termination, indicating a positive role for SPT5 in elongation (Bourgeois 
et al., 2002; Wu-Baer et al., 1998). Moreover, various genetic analyses have also 
implicated SPT5 and SPT4 in controlling elongation in vivo. In yeast S. cerevisiae, some 
spt4 and spt5 defects elicit a 6-azauracil (6AU) sensitive phenotype (Hartzog et al.,
1998). In addition, certain spt5 alleles can be suppressed by mutations in two of the 
largest subunits of pol II and by elongation factor TFIIS (Hartzog et al., 1998).
HPR1 was originally identified as playing a role in mitotic intrachromosomal 
excision recombination (Aguilera and Klein, 1988). Recently, HPR1 has been found to be 
the component of an RNA pol II holoenzyme complex involved in elongation and the 
component of a multi-subunit complex containing other putative elongation factors
9
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(Chavez and Aguilera, 1997; Chavez et al., 2000). Moreover, the absence of HPR1 
causes impairment of transcription elongation through the lacZ gene. The intensity of 
such a transcriptional impairment depends on the transcribed DNA sequence, and HPR1 
is preferentially required for transcription of either long or G+C-rich DNA sequences in 
Saccharomyces cerevisiae (Chavez and Aguilera, 1997; Chavez et al., 2001).
Although these proteins were identified as elongation factors by using genetic 
assays and in vitro biochemical studies, their effects on transcriptional elongation in vivo 
is not clear. In the yeast Saccharomyces cerevisiae, the principal limitation to 
characterizing the action of factors involved in elongation has been the lack of 
identification of specific genes whose expression is affected by defects in these 
elongation factors and the lack of the suitable in vivo elongation assay. In this thesis, I 
identified several bona fide yeast genes containing naturally occurring internal poly (A) 
sites whose elongation is impaired with rph2-10, spt5-4 and dstl defects. An in vivo 
transcriptional elongation assay was established and the effect of these elongation factors 
on elongation in vivo was thoroughly examined.
II: Investigate Roles of SPT5/SPT4 in mRNA Degradation And Their 
Relationships With The CCR4-NOT Complex
The evolutionarily conserved proteins CCR4/CAF1 belong to the CCR4-NOT 
complex. The CCR4-NOT complex exists in two forms, 1.9 MDa and 1.0 MDa in size 
(Liu et al., 1997). The smaller complex contains CCR4, CAF1, the five NOT proteins 
(NOT 1-5), CAF40 and CAF130 (Chen et a l, 2001; Liu et a l, 1998). CCR4 and CAF1 
bind a central section of NOT1 whereas the NOT2-5 proteins bind the C-terminal region
10
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of NOT 1. CAF40 and CAF130, whose precise biological functions are not known, bind 
other areas of NOT1 (Bai et al., 1999; Chen et al., 2001). The organization of the CCR4- 
NOT complex, with a distinct CCR4/CAF1 module and a NOT2-NOT5 module, 
recapitulates the functional differentiation of these two groups of proteins. CCR4 and 
CAF1, as the major cytoplasmic deadenylase complex, act to control the degradation of 
mRNA (Chen et al., 2002; Daugeron et al., 2001; Tucker et al., 2002; Tucker et al.,
2001). NOT4 protein has been found to display ubiquitin-protein ligase activity, which 
indicate a role for NOT4 in protein degradation (Albert et al., 2002). NOT1-NOT5 
proteins physically interact with TFDD and are presumed to restrict TFHD access at 
certain promoters (Badarinarayana et al., 2000; Deluen et al., 2002; Lemaire and Collart,
2000). Genetic studies also indicate a role for CCR4 in transcriptional elongation (Denis 
et al., 2001). Moreover, whole genome cDNA microarray analysis using defects of the 
components o f the CCR4-NOT complex showed that, while the CCR4-NOT facters 
particularly affected genes involved in stress response, protein degradation, pheromone 
response, DNA repair, and carbon metabolism as previously suggested, a number of 
newly identified groups of genes appear regulated by CCR4-NOT components (Cui, 
Shrivastav and Denis, unpublished results). Consistent with their multiple functions, the 
CCR4-NOT proteins have been localized to both nuclear and cytoplasmic compartments 
(Tucker et al., 2002; Tucker et al., 2001).
The most well understood biochemical function for the CCR4-NOT complex is its 
role as the cytoplasmic mRNA deadenylase. Several pieces of evidence indicate that 
CCR4 is the critical enzymatic component of the major cytoplasmic deadenylase. First, 
both ccr4 and ca.fl deletions reduce the rate of mRNA deadenylation (Tucker et al.,
11
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2001). Second, purified CCR4 displayed deadenylase activity but CAF1 solely did not 
have this activity (Chen et al., 2002; Tucker et al., 2001). Third, overexpression o f CCR4 
can suppress the deadenylation defects of a cafl strain, but CAF1 overeexpression can 
not complement a ccr4 defect (Tucker et al., 2002). Finally, mutations in the key, 
catalytic residues of CCR4 can abolish both its in vivo function and its in vitro 
deadenylase activity (Chen et al., 2002; Tucker et al., 2002). Although other components 
o f CCR4-NOT complex do not have deadenylase activity, several observations indicate 
that CCR4-NOT complex as a whole functions as the cytoplasmic mRNA deadenylase. 
First, CCR4 and CAF1 are in the same complex with the NOT proteins (Liu et al., 1998). 
Second, all components of CCR4-NOT complex are present in the cytoplasm (Tucker et 
al., 2002; Tucker et al., 2001). Moreover, deletion of NOTs and CAF1 genes can also 
result in deadenylation defects for certain mRNAs. While deleting the NOTs does not 
result in as severe effects as ccr4 observed with (Tucker et al., 2002), deleting cafl gives 
very similar phenotype and mRNA degradation defects observed with ccr4. These results 
suggest that CAF1 is critical for CCR4 deadenylase activity.
Several factors could affect CCR4 deadenylase activity. First, CCR4 deadenylase 
activity depends on its RNA substrates. CCR4 prefers RNA with at least 2A residues at 
its 3’ end, and reacts better with RNA substrates that are at least 17 nucleotides in length. 
In addition, longer RNA substrates (45 nucleotides) convert CCR4 from a slow 
distributive enzyme to a fast processive enzyme (Viswanathan et al., 2003). Second, poly 
(A) binding protein (PABl) has also been shown to inhibit CCR4 deadenylase activity in 
vitro (Tucker et al., 2001).
12
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Recently, a physical interaction between SPT5 and CCR4-NOT complex was 
identified in our lab. First, we found that immunoprecipitation of SPT5 can co- 
immunoprecipite multiple CCR4-NOT components. Two-hybrid analysis also confirms 
an interaction between SPT5 and the C-terminal region of CCR4. Second, we have 
demonstrated in vitro that purified CAF1, CCR4-C-terminus, and NOT1 can each bind 
purified SPT5. Third, CCR4 and CAF1, like SPT5, are known to associate with RPB1, 
the largest subunit o f RNA polymerase II (Chang et al., 1999). Moreover, different spt5 
alleles display either suppression or exacerbation of ccr4 defects, suggesting that not only 
there is a physical interaction between SPT5 and CCR4-NOT complex, SPT5 also 
functionally interact with CCR4-NOT complex.
In this thesis, I examined the effect of SPT5/SPT4 on mRNA degradation and 
whether it performs this effect through its physical and functional interaction with the 
CCR4-NOT complex.
13
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CHAPTER I
IDENTIFICATION OF GENES WHOSE FULL-LENGTH EXPRESSION IS 
AFFECTED BY DEFECTS IN THE TRANSCRIPTIONAL ELONGATION FACTORS 
RPB2, TFHS AND SPT5: IN VIVO EVIDENCE THAT ELONGATIONAL DEFECTS 
ENHANCE UPSTREAM POLY (A) SITE UTILIZATION
Abstract
While a number of proteins are involved in elongational processes, the 
mechanism o f action of most of these factors remains unclear primarily because of the 
lack of suitable in vivo model systems. We have identified in yeast several genes, each 
of which contain internal poly (A) sites, whose full-length mRNA formation is reduced 
by mutations in RNA polymerase II subunit RPB2 (rpb2-10 that slows the enzyme’s 
elongation rate), elongation factor SPT5 (spt5-4), or TFHS (dstl). Genes containing 
cryptic poly {A) sites (as found in the E.coli la.eZ gene), internally inserted defective 
ADH2 poly (A) signaling sequences, or naturally occurring internal poly (A) sites 
(RNA 14, CBP1, and AEP2) are subject to decreased full-length mRNA formation and 
enhanced internal poly (A) site utilization as a result of the rpb2-10, spt5-4 and dstl 
alleles. Full-length expression through yeast genes lacking internal poly (A) sites was 
unaffected by these alleles. Importantly, the rpb2-7 allele, which does not cause RNA pol 
II arrest, had little or no effect on the in vivo full-length expression of genes containing 
internal poly (A) sites. rpb2-10 and spt5-4 also promoted the utilization of upstream poly 
(A) sites for genes that contain multiple 3’ poly (A) signaling sequences, suggesting a 
role for elongation in differential poly (A) site choice. Our data suggest that defects such
14
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as rpb2-10, spt5-4 or dstl cause increased transcriptional pausing or arrest that results in 
increased deposition of poly (A) cleavage/adenylation factors and hence utilization of 
internal or upstream poly (A) sites. Transcriptional pausing/arrest can, therefore, be 
amplified and visualized in vivo if a gene contains internal poly (A) sites, allowing 
biochemical and genetic study of the elongation process.
Introduction
The regulation of the expression of eucaryotic genes can occur at different and 
multiple levels. Control of the elongation phase of transcription has been found to be 
important for a number of genes, most notably those in higher eucaryotes (Uptain et al 
1997; Conaway et al 2000). It is expected, therefore, that numerous biological controls 
would be in place to ensure that elongation occurs to the extent and degree it should to 
result in the proper levels of mRNA for the different genes in the cell. Most importantly, 
recent evidence has suggested that the elongation process is linked and critical to other 
post-transcriptional processes such as mRNA capping, splicing, 
polyadenylation/cleavage, and transport (Calvo and Manley 2001; Strasser et al 2002; 
Proudfoot et al 2002). Elongation can therefore be viewed as the center through which 
the whole quality control o f mRNA formation can be integrated (Maquat and Carmichael 
2001; Orphanides and Reinberg 2002; Proudfoot et al 2002).
Recently, in yeast and other organisms, a number of factors have been identified 
as either components of the elongating polymerase or as possible modulators of the 
process of elongation. Biochemical and in vitro studies have demonstrated or suggested a 
requirement for several of these factors in elongation. As a result of the RNA pol II
15
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structure being recently determined, it is clear that the RPB2 subunit of RNA pol II may 
play multiple roles during elongation (Cramer et al 2000). In vitro evidence confirms a 
key role for RPB2 in that RNA pol II containing either the rpb2-10 or rpb2-4 proteins 
fails to elongate well in vitro (Powell and Reines 1996). In particular, the rpb2-10 
protein causes arrest at known mammalian pause sites and requires elongation factor 
TFHS for overcoming the arrest that occurs at such sites. Moreover, the rpb2-10 allele in 
combination with a dstl (encoding TFHS) deletion causes severe defects in the synthesis 
of most mRNA in vivo (Lennon et al 1998) and reduces the induction of a number of 
other genes (Wind-Rotolo and Reines, 2001). These observations suggest that in vivo 
rpb2-10 is actually causing promiscuous arrest of RNA pol II that requires TFHS to 
suppress and overcome.
Another important factor involved in elongation are yeast proteins SPT5/SPT4 
whose higher eucaryotic orthologs are components of the DSIF complex. SPT5/4 have 
been found to be both activators and repressors of elongation. The DSIF complex is 
known to be important to repressing elongation in vitro and appears to do so by its 
interaction with the hypophosphorylated form of the RNA polymerase IICTD (Wada et 
al 1998a,b; Yamaguchi et al 1999a,b). Drosophila SPT5 in the control of hsp70 is 
known to be recruited to the transcribing polymerase, although it also may have a role in 
forming the paused RNA pol II complex at hsp70 (Andrulis et al 2000; Kaplan et al 
2000). Also, depleting SPT5 in a TAT dependent system promotes pausing and 
transcriptional termination, indicating that SPT5 can have positive roles on elongation in 
addition to previously described negative roles (Bourgeois et al 2002). Various genetic 
analyses have implicated SPT5 and SPT4 in controlling elongation in vivo (Hartzog et al
16
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1998) and initiation (Swanson and Winston 1992). In addition, certain spt5 alleles can be 
suppressed by rpb2-10, or by the presumed slowing of elongation (Hartzog et al 1998). 
The physical association of the SPT5/4 complex with RNA pol II further confirms its 
importance to RNA pol II function (Hartzog et al 1998).
In the yeast Saccharomyces cerevisiae the principal limitation to characterizing 
the action of factors involved in elongation has been the lack of identification o f specific 
genes whose expression is affected by defects in these elongation factors. For instance, 
no particular gene whose elongation is affected by these factors has been identified 
(Lennon et al 1998; Shaw and Reines 2000; (Wind-Rotolo and Reines, 2001). Similarly, 
whole genome microarray analysis with dstl and rpb9 alleles did not yield particular 
genes controlled at the level of elongation (Hemming et al 2000). Because many putative 
elongation factors also can play roles in affecting initiation (SPT5/4, PAF1 complex, 
TFIIE/IIF/IIH, RPB subunits, TFHS, CCR4-NOTs) (Swanson et al 1991; Swanson and 
Winston 1992; Tan et al 1995; Conaway et al 2000; Shaw and Reines 2000; Collart and 
Struhl 1993; Denis et al 2001; Denis and Maivar 1990), it is paramount to identify genes 
in yeast regulated at the level of elongation.
The lacZ gene, albeit an E.coli gene, has been found to be regulated at the level of 
elongation when expressed in yeast (Chavez and Aguilera 1997). The hprl deletion 
reduces transcription through lacZ apparently because of both its high G-C content and 
its extreme length (Chavez et al 2001). We have consequently examined whether other 
defects in elongation factors also affected expression through lacZ. Our results show that 
defects in SPT5 and RNA polymerase subunit RPB2 impair transcription through the E. 
coli lacZ gene but by a different mechanism than found for hprl. We show that
17
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transcription through genes containing internal polyadenylation sequences is particularly 
sensitive to spt5-4 and rpb2-10 defects. Most importantly, we identify several bona fide 
yeast genes containing naturally occurring internal poly (A) sites whose elongation is 
impaired with rpb2-10, spt5-4 and dstl defects. Our model is that spt5-4, rpb2-10 and 
dstl alleles cause pausing or arrest during elongation, resulting in increased deposition of 
poly (A) cleavage/adenylation factors at these internal poly (A) sites. These results are 
consistent with other studies linking downstream pause sites to poly (A) site utilization 
(Aranda and Proudfoot, 1999; Birse et al., 1997; Yonaha and Proudfoot, 1999; Yonaha 
and Proudfoot, 2000) and imply that elongational pausing/arrest can be studied 
biochemically and genetically in vivo using genes containing internal poly (A) sites.
Material And Methods 
Yeast Strains. Growth Conditions And Enzyme Assays
Yeast strains are listed in Table 1. Yeast were grown on YEP medium (1% yeast 
extract/2% bactopeptone), minimal medium or CAA-IT medium (Liu et al 1998) 
supplemented with an appropriate carbon source as indicated in the Figures. P- 
galactosidase activities were determined as described previously (Liu et al 1998).
RNA Analyses
Quantitative SI nuclease protection assays were conducted as described (Collart 
and Struhl 1993) using the oligonucleotides listed in Table 2. Control experiments in 
each case indicated that at the concentration of SI nuclease used, no radioactively labeled 
oligonucleotide remained if no RNA was present and that the SI nuclease assay was 
linear over the concentration of RNAs used.
18
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Total RNA and mRNA were purified and Northern blots were conducted as 
described previously (Cook and Denis, 1993; Denis et al., 1983). Oligonucleotides were 
radiolabelled at their 5’ end with T4 polynucleotide kinase as described (Chen et al., 
2002).
For the analysis of the polyadenylated species of GAL1 mRNA, GAL1 gene 
expression was induced for 15 minutes by shifting yeast from raffmose-containing 
medium to galactose-containing medium. The newly synthesized GAL1 mRNA were 
detected using an RNase H assay in which a 18-nt DNA probe (5’- 
GCCATTTGGGCCCCCTGG-3’) complementary to the sequences 133 bp upstream of 
the GAL1 translation stop codon was hybridized to total yeast RNA prior to RNase H 
cleavage (Tucker et al., 2001). The resultant GAL1 3’ polyadenylated species were 
detected by Northern analysis using a probe that was complementary to the 3’ end of 
GAL1 (5 ’-GCCCAATGCTGGTTTAGAGACGATGAT 
AGCATTTTCTAGCTCAGCATCAGTGATCTTAGGG-3’).
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FY1642 MATa his4-912Slys2-1288leu2Al ura2-52 SPT5-FLAG
FY1642-la isogenic to FY1642 except ccr4::URA3
FY1668-UH MATa his4-9128 lys2-128Sspt5-4 ura3::HIS3
FY1668-UH isogenic to FYI668-11H except ccr4::URA3
FY1635 MATahis4-9125lys2-128Sleu2Al ura3-52 spt5-242
L615 MATa his4-9125lys2-128Sura3-52 ade2-l trp5 canl-100 spt5-25
FY300 MATa his4-9125lys2-1286leu2Al ura3-52 spt5-194
GHY180 MATaura3-52 leu2Al his 4-9128 lys2-128Sspt4A2::HIS3
FY276-UT MATa leu2Al ura3::TRPl his4-9128 lys2-1288spt5-8
AYW3-1B1 MATa leu2 trpl ura3 his3
AYW3-3D1 MATa leu2 his3 ura3 leu2-k::ADE2-URA3-leu2-k hprlA3::HIS3
Z96
MATa ura3-52 Ieu2-3,U2 his3A200 rpbA297::HIS3 \pRP214 (LEU2 
RPB2) 1
Z96-la isogenic to Z96 except ccr4::URA3
Z100 isogenic to Z96 except \pKP2-4L (LEJJ2 rpb2-4)\
ZlOO-la isogenic to FY1642 except ccr4::URA3
Z106 isogenic to Z96 except \pRP2-10L (LEU2 rpb2-10)]
Z106-la isogenic to FY1642 except ccr4::URA3
Z103 isogenic to Z96 except \pRP2-7L (LEU2 rpb2-7)]
DY106-U isogenic to Z96 except dstlr.hisG
DY108 isogenic to Z106 except dstlr.hisG
EGY188 MATa ura3 his3 trpl LexAop-LEU2
EGY188-la Isogenic to EGY188 except ccr4::URA3
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Table 2. Oligonucleotide probe:








-80 -  -4
3’ probe
5’-GGCATACTTGATAATGAAAAC 







+ 1 8 -  +71
3’ probe
5 ’-GGCGGATTGGTCATCTTGTTC 

















+ 5 -+ 5 9
3’ probe
5 ’-GCGCATCGAGTAAATTTGTAT 



























-4 9 -+ 1 2
0.5 kb probe
5 ’-GCGCTCAGGTCAAATTCAGAC 
GGCAAACGACTGTCCTGGCC-3 ’ +487 -  +527
1.5 kb probe
5 ’-CGGGAAGGGCTGGTCTTC ATC 
CACGCGCGCGTACATCGGGC-3 ’ +1502-+1542
2.3 kb probe
5 ’-CGCC AATGTCGTTATCCAGCG 
GTGCACGGGTGAACTGATCGC-3 ’ +2345 -  +2386
3’ probe
5 ’-CCGCGTGCAGCAGATGGCGAT 
GGCTGGTTTCCATC AGTTGC-3 ’ +2898 -  +2938
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Results
The rpb2-10, rpb2-4, sot5-4. And spt4 Alleles Affect lacZ Reporter Expression 
Irrespective of The Promoter
A previous study of the hprl deletion showed that it affected the expression of 
the PH05-lacZ or GALl-lacZ gene in yeast although hprl had no effect on endogenous 
PH05  or GAL1 expression (Chavez and Aguilera 1997). These and other results led to 
the conclusion that HPR1 was required for efficient transcriptional elongation through the 
lacZ gene (Chavez and Aguilera 1997). We used this observation that the lacZ gene 
might contain specific sequences or structures that interfered with elongation to 
determine whether defects in other factors known or presumed to play roles in 
transcriptional elongation also failed to properly express lacZ. To conduct this analysis 
we used three lacZ reporter constructs each of which contained a different promoter: 
ADH2-lacZ, FKSl-lacZ, and GALl-lacZ (Liu et al 1998). These promoters were chosen 
to represent genes that are constitutively expressed (FKS1), inducible (GAL1), and 
subject to derepression by non-fermentative growth (ADH2). We subsequently analyzed 
the effect of defects in transcription elongation and initiation factors with each of these 
three reporters. As found for hprl, the rpb2-10, rpb2-4, spt5-4, and spt4 alleles conferred 
large decreases in lacZ expression for all reporters tested (Table 3). These effects were 
not likely to be due to effects on the respective promoters as spt5-4 does not reduce GAL1 
or ADH2 expression (data not shown; also see Figure 3). rpb2-10 is known to reduce 
GAL1 steady state mRNA but does so by only 1.4-fold (Wind-Rotolo and Reines, 2001), 
and it had no effect on ADH2 derepression (Figure 3). In addition, these reductions in
22
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lacZ expression by the spt5-4 and rpb2-l0 alleles were not the result o f increased rate of 
lacZ mRNA degradation (data not shown).
Another rpb2-7 allele, which like rpb2-4 and rpb2-10 confers 6AU sensitivity 
(Powell and Reines 1996), did not display a consistent major effect on the lacZ reporters 
(Table 3). Other alleles of SPT5 (spt5-8 and spt5-242) had much less effect on lacZ 
expression (Table 3). Moreover, defects in the elongation factors ELP1 (Otero et al
1999) or SPT16 (Oiphanides et al 1999) did not affect lacZ expression (data not shown). 
We conclude that the rpb2-10, rpb2-4, spt5-4, and spt4 alleles are affecting an apparently 
post-initiation step in the expression of the lacZ gene. Importantly, the rpb2-4- and rpb2- 
10-containing RNA pol II have been shown in vitro to display increased transcriptional 
arrest whereas rpb2-7-RNA pol II did not (Powell and Reines 1996).
The effect o f a number o f factors important to transcriptional initiation was also 
tested using this assay. Defects in none of the CCR4-NOT complex components (except 
not3-2) displayed consistent decreases in lacZ gene expression (Liu et al 1998; Chen et al 
2001; data not shown). The not3-2 effect on lacZ expression was found, however, to 
result from dramatic decreases in /acZ-reporter plasmid stability (data not shown). 
Deleting the RNA pol II holoenzyme components SRB9, -10, -11, SIN4, and GAL11 also 
displayed no consistent decreased effects on lacZ expression (data not shown). Deletion 
of the SAGA components ADA2 and GCN5 also were found to only affect one or 
another of the lacZ reporters but not all three, suggesting their effects were limited to 
control of specific promoters (data not shown; Chiang et al 1996; Berger et al 1992).
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Table 3
Effects of elongation defects on /acZ-reporter activities
Strain Relative B-ealactosidase activitv
FKSl-lacZ ADH2-lacZ GALl-lacZ
WT 100 100 100
hprl 2.3 1.6 2.2
rpb2-4 20 12 5.5
rpb2-10 24 13 15
rpb2-7 N.D. 290 56
spt5-4 23 2.9 4.1
spt5-8 65 35 56
spt5-242 N.D. 59 51
spt4 1.5 4.9 0.50
Table 3: p-galactosidase activities were determined for each allele and its corresponding 
isogenic wild-type parent containing the lacZ reporter as indicated. In order to ease 
comparison between strains, all wild-type parent values were set to 100 for each reporter. 
FKSl-lacZ was assayed on medium containing 4% glucose, ADH2-lacZ on 2% 
ethanol/2% glycerol, and GALl-lacZ on 2% galactose/2% raffmose. All values represent 
the average o f five separate transformants. Standard errors of the mean (SEMs) were less 
than 20%.
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The rob2-10. rob2‘4. sptS-4. And sot4 Alleles Reduce The Ability of RNA Pol II to 
Form Full-length lacZ mRNA
To address whether transcriptional elongation through the lacZ gene was being 
impaired by the above-described rpb2, spt5, and spt4 alleles, we used the quantitative SI 
nuclease protection assay (Collart and Struhl 1993) to identify the abundance of lacZ 
transcripts that were full-length. To do this, we compared the abundance of total lacZ 
mRNA to the abundance of the full-length lacZ mRNA. Previously, it was shown using 
Northern analysis that an hprl deletion blocked the synthesis of lacZ mRNA (Chavez and 
Aguilera 1997). In our assay system, hprl similarly displayed an inability to form full- 
length lacZ mRNA regardless o f the promoter: in an hprl strain compared to its isogenic 
parent, six-fold less full-length lacZ mRNA (corresponds to 3' end bands) was observed 
as compared to total lacZ RNA (corresponds to 5' end bands) (Figure 1 A; data not 
shown).
As shown in Figures IB and 1C, the rpb2-10, rpb2-4, spt5-4, and spt4 alleles 
which displayed consistent reductions in overall lacZ reporter expression concomitantly 
displayed reduced levels of full-length lacZ mRNA formation as compared to the 
quantity o f total lacZ mRNA that was present (Figure IB, two-to three-fold effects for 
rpb2-4 and rpb2-10 and in Figure 1C, three- to seven-fold for spt5-4 and spt4). In 
contrast, rpb2-7 (Figure IB), spt5-8, spt5-25 and spt5-194 (Figure 1C) had no significant 
or less effect on formation of full-length lacZ mRNA. The same results obtained with 
FKSl-lacZ (Figure 1) were obtained with ADH2-lacZ (data not shown), indicating that 
these effects were independent of the promoter. These data confirm a direct correlation 
between the effect these elongation factors have on lacZ reporter expression and the
25
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Figure 1. SI nuclease protection analysis of the effect of HPR1, RPB2, SPT4 and SPT5 
defects on full-length lacZ mRNA formation.
lacZ 5' and 3' end RNA levels were quantified using an SI nuclease protection assay with 
probes directed against the 5' end of lacZ RNA and 2.9 kb downstream of the lacZ 
initiation site, respectively (see Table 2). Total RNA was extracted and the ratios of 3’ to 
5’ RNA levels were quantified using a Phosphoimager. The values are normalized based 
on the ratio for wild-type and the average ratio is given below each Figure except as 
indicated.
(A) hprl reduces full-length lacZ mRNA formation. Strains AYW3-1B1 (WT, lane 1) 
and AYW3-3D1 (hprl, lane 2) containing plasmids expressing FKSl-lacZ were grown 
on 4% glucose-containing CAA-U medium. The values represent the average of five 
determinations and the SEM for hprl was 20%.
(B) rpb2-4 and rpb2-10 alleles reduce full-length lacZ mRNA formation. Growth 
conditions with FKSl-lacZ and calculations were conducted as described in (A). WT, 
strain Z96 (lane 1); rpb2-4, strain Z100 (lane 2); rpb2-10, strain Z106 (lane 3) and rpb2- 
7, strain Z103 (lane 4). The values represent the average of five determinations for rpb2-4 
with an SEM of 4%, four determinations for rpb2-10 with an SEM of 7%, and a single 
determination for rpb2-7. Similar results were observed for rpb2-7 with the analysis of 
ADH2-lacZ mRNA expression.
(C) spt5-4 and spt4 alleles reduce full-length lacZ mRNA formation. Growth conditions 
with FKSl-lacZ and calculations were conducted as described in (A). WT, strain FY1642 
(lane 1); spt5-4, strain FY1668-uH (lane 2); spt4, strain GHY180 (lane 3); spt5-194, 
strain FY300 (lane 4); spt5-8, strain FY276-uT (lane 5); and spt5-25, strain L615 (lane 
6). The spt5-4 value represents the average of eight determinations with an SEM of 8%. 
The other values represent single determination, although similar results were obtained 
for these defects with the analysis of ADH2-lacZ mRNA expression.
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Figure 1:
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formation of full-length lacZ mRNA. Importantly, only the rpb2 alleles which displayed 
reduced ability to transcribe through elongational blocks in vitro (Powell and Reines 
1996) failed to form full-length lacZ mRNA in vivo.
It must be mentioned in regards to these SI analyses that our experiments indicate 
in agreement with other studies (Luebke et al., 2003; Woolf et al., 1992) that 
oligonucleotide probes, due to differences in length and sequence, can display different 
degrees o f  stable binding to the same mRNA and hence different apparent levels o f 
mRNA. Because of these inherent differences in stability of binding between the 
individual probes and a given mRNA, only the ratios of 5' to 3' mRNA levels can be 
compared between a particular mutant and its isogenic parent. Also, several o f these 
mutants can affect the overall abundance of a particular mRNA that results in either an 
increased or reduced level of total mRNA levels relative to that of wild-type (for 
example, see spt5-4, Figure 1C). However, as we are interested in comparing the relative 
ability of different elongation defects to reduce the formation of the full-length mRNA, 
alterations in the level of initiation of the transcript do not affect these comparisons.
The Effect on lacZ mRNA Formation Is Not Due to Increased mRNA 31 End 
Degradation.
The reduced level of formation of full-length lacZ mRNA could be attributed 
either to a block in elongation through the lacZ gene or to increased degradation o f the 3' 
end of the mRNA as compared to the degradation of the 5' end. To address this latter 
possibility we utilized the GALl-lacZ reporter to determine the rate of degradation of the 
5' and 3' ends of the lacZ mRNA following the shutting off of GALl-lacZ transcription by 
growth on glucose-containing medium. However, neither the spt5-4 nor the rpb2-10
28
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allele augmented the rate of degradation of the 3' end of the lacZ transcript relative to the 
5' end (data not shown).
The Block to Transcriptional Elongation in lacZ Occurs at Multiple Sites
We subsequently examined where in the lacZ gene the block to elongation was 
occurring using the SI nuclease protection assay with probes spaced across the lacZ gene. 
In spt5-4, rpb2-4 and rpb2-l0 mutation backgrounds, lacZ mRNA synthesis appeared 
unimpeded through the first 500 bp of the lacZ gene (Figure 2). However, using probes 
at 1.5,2.3, and 2.9 kb, decreased levels of lacZ 3'-end mRNA formation became 
apparent. In moving from 1.5 to 2.9 kb, at each step an additional decrease in lacZ 3' end 
mRNA formation was observed, suggesting the existence of multiple sites for blockage 
o f mRNA synthesis (Figure 2).
29
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 2
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3 :5' 1.0 1.2 1.0 0.69 1.0 0.50 1.0 0.43
3' probe
location 0.5 kb 1.5 kb 2.3 kb 2.9 kb
Figure 2. spt5-4 and rpb2 alleles affect full-length lacZ RNA formation at multiple sites. 
The 3' lacZ, probes for conducting the SI nuclease protection assays are listed in Table 2. 
In all cases the 5' probe corresponded to sequences at the initiation codon of lacZ. 
Growth conditions, assays and analyses were conducted as described in Figure 1. The 
rpb2 (panel A) and spt5-4 (panel B) strains contained FKSl-lacZ. The values represent 
the data as presented, but two to three other repeats gave the same pattern of effects and 
similar results were also observed when analyzing ADH2-lacZ.
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sot5 And rob2 Defects May Enhance Use of Cryptic Polv (A) Sites in lacZ
The above observations indicate that lacZ mRNA formation is particularly 
sensitive to SPT5 and RPB2 defects. One model to explain this data is that 
transcriptional pausing or arrest caused by the spt5-4, spt4, rpb2-10, and rpb 2-4 alleles 
results in increased deposition of poly (A) site cleavage/adenylation factors at known 
cryptic poly (A) sites located within the lacZ gene (Russnak et al 1995). Alternative 
hypotheses for these effects at lacZ gene have been suggested for how hprl affects lacZ; 
that is, the long length of lacZ or its high G-C content contributes to its impaired 
transcription (Chavez et al 2001). spt5-4 and rpb2-10, however, unlike hprl had no 
effect on transcription through the native YAT1 gene which is extremely G-C rich (Figure 
3) and which is affected by hprl (Chavez et al 2001). Likewise spt5-4 and rpb2-10 did 
not affect transcription through NOT1, a 6.5 kb transcript (Figure 3), suggesting that it is 
not the length per se of lacZ which is impeding expression. Finally, rpb2-4, rpb2-10, and 
spt5-4 did not affect full-length ADH2 expression (Figure 3) although they all affected 
ADH2-lacZ (Table 3; data not shown).
If the poly (A) usage model were correct, the incompletely formed lacZ RNA 
would be polyadenylated. We would expect, therefore, that when polyadenylated 
enriched RNA is analyzed that both spt5-4 and rpb2-10 should reduce the formation of 
full-length lacZ mRNA to the same extent they reduced full-length lacZ RNA formation 
when total RNA is analyzed. As shown in Figure 4, rpb2-10 and spt5-4 affected the 
formation of full-length lacZ polyadenylated RNA to the same degree as they affected the 
formation of full-length lacZ RNA isolated from total RNA. These results support the 
model that spt5-4 and rpb2-10 are enhancing utilization of cryptic poly (A) sites in lacZ
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Figure 3. spt5 and rpb2 alleles do not affect elongation through the ADH2, NOT1 and 
YATl gene.
Cells were grown on YEP medium containing 4% glucose (for NOT1), 2% galactose/2% 
raffinose (for YATl) or 2% ethanol (for ADH2). 5' and 3' end RNA levels were 
quantitated as described in Figure 1 using 5' and 3' probes specific to ADH2, NOT1 and 
YATl respectively (Table 2). To quantitate YATl 5’ and 3’ RNA levels, yeast strains 
were transformed with a GAL1-YAT1 plasmid (Chavez et al., 2001). The values represent 
the data as presented but repetitions showed no significant differences.
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Figure 4:
Figure 4. rpb2-10 and spt5-4 alleles reduce full-length lacZ mRNA formation by 
increasing partial-length lacZ mRNA formation.
Both total RNA (A: lanes 1 and 2; B: lanes 1 and 2) and poly (A) RNA (A: lanes 3 and 4; 
B: lanes 3 and 4) were extracted and analyzed using an SI nuclease protection assay. SI 
nuclease protection assays, growth conditions, and calculations were conducted as 
described in Figure 1. The values represent the data as presented.
(A) WT, strain Z96 (lanes 1 and 3) and rpb2-10, strain Z106 (lanes 2 and 4).
(B) WT, strain FY1642 (lanes 1 and 3) and spt5-4, strain FY1668-uH (lanes 2 and 4)
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and are not simply causing RNA pol II to cease transcription, resulting in shortened 
RNAs lacking poly (A) tails. Northern analysis, however, was unable to detect discrete 
shortened RNAs, probably because of multiple diffuse ends and more rapid turnover in 
the cell of the shortened RNAs (data not shown).
sutS-4 And rob2-10 Enhance Utilization of Defective ADH2 Poly (A) Sites
If spt5-4 and rpb2-10 were causing increased pausing or arrest that results in 
subsequent upstream poly (A) site utilization, then it would be expected that these 
mutations should be able to enhance use of known defective poly (A) sites found internal 
to genes. To test this hypothesis, we utilized the previously described ADH2 defective 
poly (A) sites that have been used in a poly (A) site usage assay (Hyman et al 1991). For 
this assay, as shown in Figure 5A, the 3' end of the ADH2 gene containing its poly (A) 
signaling sequences has been embedded within the RP51 intron. Usage of the ADH2 
poly (A) cleavage site promotes the formation of a short mRNA that does not include 
downstream RP51 sequences that are fused to lacZ. Read-through of the poly (A) site, on 
the other hand, promotes splicing of the intron and synthesis through lacZ. We 
monitored these two alternative events by quantitating with an SI nuclease protection 
assay the relative amount of mRNA that is expressed using either probe 1 that overlaps 
the 5' RP51 junction of the exon and intron (thus measuring mRNA resulting from ADH2 
poly (A) site usage) or probe 2 that is at 150 bp within the lacZ gene (thus measuring 
RNA in which the poly (A) site has not been used and splicing has occurred). As shown 
above in Figure 2, transcription through the first 500 bp of lacZ is unaffected by spt5-4 or 
rpb2-10 alleles.
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Three plasmids containing this setup were used: pLIOl which has a wild-type 
ADH2 y  end sequence, pL401 which contains a T to G alteration upstream of the ADH2 
poly (A) site that blocks ADH2 poly (A) site usage by 10-fold and pL402 which contains 
two single nucleotide deletions upstream of the ADH2 poly (A) site that also blocks poly
(A) site usage (Figure 5A). As depicted in Figure 5B, in a wild-type strain, with pLIOl 
the ADH2 poly (A) site is used and very little read-through mRNA is made (upper and 
lower panel, lane 1). With both pL401 and pL402 (lanes 2 and 3, respectively) poly (A) 
site usage is weakened at ADH2 and correspondingly read-through into the lacZ gene 
occurs. These are the same results as previously obtained by Hyman et al 1991.
In an spt5-4 strain, however, the defective poly (A) sites in pL401 and pL402 
display increased usage. The ratio of ADH2 poly (A) site usage RNA to that of read- 
through RNA increased about five-fold in both cases relative to the ratio observed in 
wild-type (Figure 5B, upper panel, lanes 5 and 6 compared to lanes 2 and 3). In contrast, 
the spt5-242 allele which does not affect lacZ expression correspondingly does not affect 
poly (A) site usage in pL401 and pL402 (Figure 5B, upper panel, lanes 8 and 9). The 
exact same results are obtained for the rpb2 alleles as observed for spt5. rpb2-I0, which 
reduces lacZ expression, increased the ratio of poly (A) site usage RNA to that o f read- 
through RNA by about three- and five-fold relative to the wild-type ratio in plasmids 
pL401 and pL402, respectively (Figure 5B, lower panel, lanes 5 and 6, compared to lanes 
2 and 3). rpb2-7 which does not affect lacZ also does not affect pL40l and pL402.
These data provide strong support for the model that the difficulties in transcribing 
through the lacZ gene arise as a result of increased cryptic poly (A) site usage.
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One alternative explanation for these results with the ADH2 poly (A) usage assay 
is that spt5-4 and rpb2-10 are decreasing the rate of degradation of the short mRNA that 
terminates in the intron as compared to the read-through mRNA. This result is unlikely 
in that as observed in lane 4, both upper and lower panels of Figure 5B, spt5-4 and rpb2- 
10 do not correspondingly augment the levels o f the short mRNA relative to the long 
mRNA. We did, however, quantitate the mRNA half-lives for the short and long mRNA 
and found that spt5-4 had no effect on the half-life of either mRNA (data not shown).
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Figure 5. rpb2-10 and spt5-4 enhance utilization of defective ADH2 poly (A) sites 
embedded within the RP51 gene.
(A) The internal ADH2 poly (A) site assay as previously described (Hyman et al 1991) is 
depicted. Plasmid pLIOl contains the RP51 locus fused to the lacZ gene in which the 3’ 
end of ADH2 (containing the signals for poly (A) cleavage/adenylation) is inserted in the 
RP51 intron. ADH2 poly (A) site usage results in a short transcript ending in the intron 
that will be detected with probe 1 (5 ’-GCCTCCTTTAGTCCATATTAACATA 
CCATTTTGTTATTGC-3’; see panel B, lane 1). Plasmids pL401 and pL402 contain the 
same ADH2 sequence inserted in the intron of RP51 except each contains mutations in 
theADH2 poly (A) recognition sequences resulting in substantial read-through and the 
formation of full-length mRNA transcript that is detectable with probe 2 (5’- 
GCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGAT 
CGGTGCGGGCCAGAA-3’; see panel B, lanes 2 and 3).
(B) SI nuclease protection analysis of the relative levels of read-through and short 
transcripts. Strains were pregrown in 4% glucose-containing CAA-IT medium at 30°C for 
20 hr, and then shifted to CAA-IT medium with 2% galactose/2% raffinose at 30°C for 4 
hr. RNA was subjected to SI nuclease protection assays as described in Figure 1 using 
probe 1 and 2 (panel A).
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rob2-16 Reduces Full-len2th mRNA Formation From Yeast Genes That Contain
Internal Polv (A) Sites
Since rpb2-10 has been shown to increase pausing/arrest in vitro the most likely 
interpretation o f the above results is that increases in pausing downstream o f the ADH2 
poly (A) site caused by the rpb2-10 allele promotes greater deposition of poly (A) site 
cleavage/adenylation factors at the ADH2 poly (A) sites. These results also imply that 
rpb2-10 pausing will become manifest in reduced full-length gene expression of native 
yeast genes if  partially functional poly (A) sites are present internal to a gene. In yeast, 
three genes, RNA14, AEP2, and CBP1, have been shown to contain internal inefficiently 
utilized poly (A) sites (Sparks and Dieckmann 1998; Sparks et al 1997). RNA14 contains 
two such sites whereas AEP2 and CBPI each contain one. We, therefore, assayed the 
effect of rpb2-10 and rpb2-7 on the expression through RNA14, AEP2, and CBPI (Figure 
6). Using 5' and 3' probes to the RNA14 mRNA, rpb2-10 reduced the level of the 3' RNA 
relative to the amount of 5' RNA (Figure 6, upper panel, lane 5 compared to lane 4).
Over seven such experiments the average drop in the 3’:5’ ratio in an rpb2-10 mutant was 
0.62±0.045 (SEM). The rpb2-7 allele again displayed much less of an effect (Figure 6, 
upper panel, lane 6) for an average decline in the 3':5’ ratio for five determinations of 
0.91± 0.082.
We reexamined these results using Northern analysis to verify whether one or 
both of the RNA14 internal poly (A) sites was being preferentially affected. As shown in 
Figure 7, lanes 3 and 5, rpb2-10 resulted in diminished full-length mRNA formation and 
augmented levels of the shortest (1.1 kb) mRNA. This result agrees with the SI analysis 
displayed in Figure 6, top panel. It suggests further that the two internal poly (A) sites in
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RNA14 might behave differently or that there are specific sequences across the RNA14 
gene that display different responsiveness to rpb2-10. Importantly, rpb2-10 also reduced 
CBPI full-length formation (Figure 6, lower panel, lane 4) and that of AEP2 (Figure 6, 
middle panel, lane 4). As mentioned above, rpb2-10 did not affect expression through 
several other genes analyzed, ADH2, NOT1, and YAT1, indicating that it specifically 
affects expression through genes containing internal poly (A) sites. However, hprl had 
no affect on RNA14 full-length expression (Figure 6, upper panel, lane 8) or that of AEP2 
(middle panel), confirming that hprl operates by a different mechanism than rpb2-10 in 
affecting elongation. It should be noticed that rpb2-7 did display some enhanced internal 
poly (A) site utilization at RNA14 (Figure 7, lane 3) and at AEP2 (Figure 6, middle panel, 
lane 5). While these effects are consistently less than that observed with rpb2-10, they do 
indicate that the rpb2-7 allele, which confers a 6AU phenotype in vivo (Powell and 
Reines, 1996), consistent with an elongational defect, can affect elongation under certain 
in vivo condition.
spt5-4 also resulted in decreased full-length formation for RNA14 (Figure 6, upper 
panel, lane 2) with an average fold decrease in the 3’:5’ ratio of 0.67± 0.046 for six 
experiments. In contrast, spt5-242 had little apparent effect on full-length RNA 14 
expression (Figure 6, upper panel, lane 3) with an average drop in the 3’:5’ ratio of 0.91± 
0.12 for four experiments. These results were also confirmed by Northern analysis 
(Figure 7). spt5-4, however, displayed no consistent effect on CBPI or AEP2 expression 
(Figure 6A, lower and middle panel, respectively), suggesting that either there is 
sequence specificity to its pausing, its effects are weaker, or that the multiple poly (A) 
sites within RNA14 allow greater amplification of its putative pausing.
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Figure 6. rpb2-10 and spt5-4 reduce full-length expression of yeast genes containing 
internal poly (A) sites.
Cells were grown on minimal medium with 4% glucose overnight and shifted to 2% 
glycerol-containing minimal medium for 6 hours. SI nuclease protection assays were 
conducted as described in Figure 1 using probes specific to the 5’ and 3’ ends of RNA 14, 
CBPI, and AEP2 (Table 2). The values represent the average of three to seven repetitions 
except for hprl and for the rpb2-7 effect on CBPI which were single experiments. SEMs 
not indicated in the text were less than 10% except for rpb2-10 on CBPI which was 20%.
41
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 6
RNA14
















3’:S' 1.0 0.91 
lanes 1 2






I t  3 2£  &• S-
S' probe ■ * * *
3’ probe * * *
3's5' 1.0 1.1 1.0 0.31 0.85
lanes 1 2 3 4 5
42






Figure 7. Northern analysis indicates that spt5-4 and rpb2-10 cause reduced full-length 
RNA 14 mRNA formation and increased internal poly (A) site utilization.
Cells were grown as described in Figure 6. Both total RNA (lanes 1 to 3) and poly (A) 
RNA (lanes 4 to 7) were extracted and subjected to Northern analysis using the 5 ’ probe 
from RNA14. Values represent the data as presented. Repeat experiments gave similar 
data.
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Deletion of TFIIS Also Reduces Full-length Expression of RNA14
The above results indicate that defects in transcriptional elongation in vivo can be 
visualized by monitoring the use of internal poly (A) sites. It had already been previously 
shown that a dstl deletion blocks GALl-lacZ expression (Kulish and Struhl 2001). We 
subsequently examined the effect of dstl using the defective ADH2 poly (A) signal 
inserted into the RP51 gene. As shown in Figure 8A, lane 4 compared to lane 2, dstl, like 
rpb2-10 and spt5-4 (Figure 5B), caused the formation of increased truncated RPSl RNA 
(for dstl lane 4, about 2.0-fold more shortened transcript relative to read-through 
transcript as compared to that found in wild-type, lane 2), consistent with dstl 
augmenting internal ADH2 poly (A) site utilization. To further test this hypothesis we 
subsequently examined the effect of a TFIIS deletion on RNA 14 expression. As shown in 
Figure 8B, a dstl deletion reduced full-length RNA expression by 1.6-fold. This result 
was confirmed by Northern analysis in which the shortest transcript was increased in 
abundance relative to the full-length transcript by two-fold (Figure 8C). Combining a 
dstl deletion with an rpb2-10 allele did not result, however, in any significantly worse 
effects than observed with just the rpb2-10 allele alone (Figure 8C). These observations 
identify the first native gene in vivo whose elongation is impaired by deletion of TFIIS 
and confirm the use of the poly (A) amplification elongation assay.
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Figure 8. dstl has similar effects on full-length RNA formation as rpb2-10.
(A) WT, strain Z96 (lanes 1 and 2) and dstl, strain DY106-U (lanes 3 and 4) were 
analyzed for their effects on ADH2 poly (A) site usage as described in Figure 5B. 
Plasmids pLIOl and pL401 are as in Figure 5.
(B) RNA14 full-length RNA expression was analyzed as described in Figure 6. Total 
RNA was extracted from strains Z96 (WT), Z103 (rpb2-7), Z106 {rpb2-10), DY106-U 
(dstl) and DY108 (dstl rpb2-10). Values represent the data as presented. Repeat 
experiments gave similar data.
(C) Northern analysis of RNA 14 mRNA levels in strain backgrounds described above 
was conducted as described in Figure 7. Values represent the data as presented. Repeat 
experiments gave similar data.
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rob2-10 And sot5-4 Affect Polv (A) Site Usage at The 3’ End of Genes
Differential poly (A) site choice at the 3’ ends of genes can be regulated in 
response to a variety of biological influences (Edwalds-Gilbert et al., 1997). The above 
effects of elongation defects on internal upstream poly (A) site utilization suggest that 
elongation may also play a role in regulating poly (A) site choice. To test this prediction, 
we analyzed poly (A) site utilization for the GAL1 gene which contains two poly (A) sites 
about 50 and 160 bp downstream of its translation stop codon (Graber et al., 2002; 
Miyajima et al., 1984, see Figure 9, top panel). Newly synthesized GAL1 polyadenylated 
mRNA were created by inducing GAL1 expression for 15 minutes in galactose- 
containing medium followed by repression of GAL1 mRNA synthesis with the addition 
o f glucose. The 3’ ends of GAL1 mRNA were detected using an RNase H assay (Tucker 
et al., 2001) and a DNA probe that was complementary to sequences present in both 
species (Figure 9, top panel). Two polyadenylated species migrating at about 380 and 275 
nt were identified (Figure 9, bottom panel) that corresponded to poly (A) sites at about 
160 bp and 50 bp, respectively, downstream of the GAL1 stop codon. Each mRNA 
species contained 80 nt of poly (A) as determined by a deadenyiation assay (data not 
shown; Tucker et al. 2001). As shown in Figure 9, lanes 1 and 4, the downstream site is 
preferred by about two-fold over the upstream site in the wild-type strain. In a rpb2-10 
background, the use of the GAL1 upstream poly (A) site was increased by about 2-fold 
(Figure 9, lane 3, rpb2-10, compared to lane 1, wild-type), whereas the rpb2-7 allele had 
no effect on GAL1 poly (A) site utilization (Figure 9, lane 2). Similarly, in an spt5-4 or 
spt4 strain background, the use of the upstream site is increased by 1.6-fold and 2.0-fold, 
respectively (Figure 9, lanes 5 and 6). The spt5-242 allele which does not affect internal
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Figure 9. rpb2-10, spt5-4 and spt4 affect 3’ end poly (A) site choice at GALL 
Top panel - Diagram of GAL1 gene RNA. The two poly (A) sites located 50 bp and 160 
bp downstream of the stop codon are indicated as are the RNase H probe and the 
Northern probe. Bottom panel -  Northern analysis of GAL1 mRNA.
Yeast were grown on galactose-containing medium for 15 minutes followed by glucose 
addition upon which total RNA was extracted. Newly synthesized GAL1 polyadenylated 
mRNA species were detected using an RNase H assay (Tucker et al., 2001). GAL1 
specific transcripts were identified by Northern analysis. The larger RNA species 
(migrating at about 390 nt) corresponds to a poly (A) cleavage site about 160 bp 
downstream of the GAL1 gene translation stop codon and the smaller RNA (migrating at 
about 275 nt) to a cleavage site about 50 bp downstream of the stop codon. Each mRNA 
species carries a poly (A) tail measured at about 80 nt by a deadenylation assay (data not 
shown). The values represent the average ratio of the 275 nt species to that of the 390 nt 
species for two to five determinations with SEMs less than 20%.
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poly (A) site utilization (see above) had no effect on augmenting the GAL1 upstream poly 
(A) site usage (data not shown). rpb2-10, spt5-4, and spt4 also did not enhance the 
stability of the short GAL1 mRNA relative the that of the long GAL1 mRNA (data not 
shown). These results confirm our prediction that elongation defects enhance utilization 
of upstream poly (A) sites and indicate that regulating the elongation process will be 
critical to 3’ end poly (A) site choice.
Discussion
In this report we have identified native yeast genes whose full-length mRNA 
formation is significantly reduced by defects in the elongation factors RPB2, SPT5 and 
TFIIS. The experiments represent the first demonstration in vivo of genes whose 
transcriptional elongation is regulated by these factors as previous studies, including 
microarray analyses, were unsuccessful in clearly identifying such genes (Hemming et 
al., 2000; Shaw and Reines, 2000; Wind-Rotolo and Reines, 2001). In addition, we have 
shown that expression through other chimeric yeast gene constructs and that o f the E. coli 
lacZ gene are also affected by RPB2, SPT5 and TFHS defects. The common feature of 
these genes and constructs is their containing internal poly (A) sites. These observations 
should aid the study of elongation in vivo and allow the development of genetic assays 
for the identification of novel elongation factors and new relationships among known 
factors.
It has been shown previously in vitro and in vivo that transcriptional pausing 
downstream to a poly (A) site promotes polyadenylation/cleavage of the RNA both in 
yeast and mammalian cells (Birse et al. 1997; Aranda and Proudfoot 1999; Yonaha and
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Proudfoot 1999). These observations are consistent with several observations for the 
requirement of RNA polymerase II in 3' processing (Hirose and Manley 1998;
McCracken et al 1997(Proudfoot et al., 2002). We have established in this report that 
defects in the SPT5, SPT4, RPB2 and TFIIS, all factors involved in transcriptional 
elongation, affect the mRNA formation in vivo of genes containing internal poly (A) 
sites. We postulate, therefore, that transcriptional pausing caused by defects in elongation 
factors enhances the internal poly (A) site usage and consequently increases truncated 
mRNA formation relative to full-length mRNA.
Several pieces of evidence support our hypothesis. First, mutations in SPT5, SPT4 
and RPB2 (such as spt5-4, spt4, rbp2-4 and rpb2-10 alleles) reduced full-length lacZ 
RNA formation, a gene known to contain cryptic poly (A) sites (Russnak et al., 1995). 
Other SPT5 or RPB2 mutations had no effect on full-length lacZ RNA formation, 
indicating that this effect was allele specific. Second, the truncated lacZ RNA were 
polyadenylated. Third, these SPT5 and RPB2 defects did not affect the full-length mRNA 
formation for genes, such as YAT1 or NOT1, containing high G-C content or excessive 
length which lacked internal poly (A) sites, indicating that their effects on elongation 
occurred by a mechanism different from or in addition to that ascribed to HPR1 (Chavez 
et al 2001). Fourth, we showed that spt5-4, rpb2-10 and dstl alleles can enhance the 
usage of defective ADH2 poly (A) sites embedded within the RP51 gene. Other SPT5 or 
RPB2 alleles which did not affect lacZ expression also had no effect on ADH2 defective 
poly (A) site usage. Importantly, the rpb2-10 allele which is known to cause increased 
pausing in vitro and to block in vitro transcriptional elongation resulted in enhanced 
internal poly (A) sites usage whereas the rpb2-7 allele which does not block in vitro
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elongation did not display the same effects. Fifth, we showed that full-length RNA 
formation of several yeast genes with known internal poly (A) sites displayed decreased 
full-length mRNA expression with rpb2-10 and to a lesser extent with spt5-4 and dstl. 
Finally, the rpb2-10, spt5-4 and spt4 defects affected 3’ end poly (A) site choice in which 
the usage of the upstream poly (A) site became preferred in strains carrying these defects.
That the usage of the upstream poly (A) site is always enhanced relative to that of 
the downstream site with these elongation mutations suggests that RNA pol II pausing is 
occurring throughout the gene and that deposition of poly (A) site cleavage factors 
becomes favored at the first available poly (A) signal. Our results also imply that at 
normal genes where rpb2-10 is not having an apparent effect on 3' end formation, such as 
ADH2, NOT1, YAT1, or the first 1.0 kb of lacZ, rpb2-10 induced RNA pol II pausing is 
probably still occurring but is not significant enough in vivo to cause reduced levels o f 3’ 
RNA formation relative to that o f 5’ RNA levels. Only when a cryptic or defective poly 
(A) site is present can the pausing be "amplified" and visualized as reduced normal 3' end 
formation due to increased poly (A) site usage. This interpretation is consistent with the 
observation that rpb2-10 did not appear to affect transcription in vivo even when a known 
in vitro arrest site is introduced into a gene (Wind-Rotolo and Reines, 2000). Relatedly, 
dstl did not affect RNA pol II occupancy at the lacZ gene (Kulish and Struhl, 2001), 
implying that enhanced pausing caused by dstl or rpb2-10 may not have noticeable 
effects on measurable RNA pol II association with the gene. The known effects of rpb2- 
10, dstl, spt5-4 or spt4 on many genes’ expression either positively or negatively 
(Swanson and Winston, 1992; Wind-Rotolo and Reines, 2001) must therefore be 
interpreted carefully as to whether they are due to transcriptional initiation or elongation
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defects. That is, although we did not observe with these defects reductions in full-length 
mRNA formation for long genes, such as NOT1, or genes with a very high G-C content, 
such as YAT1, this does not imply that spt5, rpb2, or dstl strains were not impaired in 
transcribing through these genes. For example, YAT1 total mRNA expression was 
decreased in an spt5-4 or rpb2-10 background, but we are unable to ascertain whether 
this effect is at the level of transcriptional initiation or not.
Interestingly, it has been shown that non-fermentative growth conditions promote 
increased poly (A) site cleavage at the RNA14 1.1 kb site and enhanced internal poly (A) 
site cleavage at CBPI and AEP2 (Sparks and Dieckmann 1998). These effects o f non- 
fermentative growth on RNA14, CBPI, and AEP2 expression are similar to that observed 
for rpb2-10 and suggest that they occur by a similar mechanism, that is, by causing 
increased RNA pol II pausing. Several stress conditions have also been observed to 
enhance SUA7 upstream poly (A) site utilization (Hoopes et al., 2000). Non-fermentative 
growth and other stress conditions may be impairing elongation and thereby altering poly 
(A) site utilization. However, the effects of the several elongation defects on internal poly
(A) site usage that we observed would occur in addition to the non-fermentative growth 
effect since all of our experiments were conducted under glycerol growth conditions.
While rpb2-10 can result in decreased full-length RNA formation for several 
yeast genes containing internal poly (A) sites such as RNA14, CBPI and AEP2 (Sparks 
and Dieckmann 1998; Sparks et al 1997) and differential 3’ end poly (A) usage at GAL1, 
spt5-4 only clearly affected full-length RNA14 RNA formation and 3’ end choice of 
GALl. This difference in behavior may be due to sequence differences between RNA14, 
CBPI and AEP2. While CBPI and AEP2 contain one internal poly (A) site, RNA 14
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contains two internal poly(A) sites, which may allow a greater amplification of the effect 
caused by pausing/arrest. RNA14 and the 3’ end of GAL1 may also contain specific 
sequences that can result in more pausing. Alternatively spt5-4 allele may have a weaker 
effect on elongation as compared to rpb2-10.
It could be argued that the spt5, spt4, rpb2 and dstl alleles are affecting full- 
length RNA formation, not by blocking RNA elongation, but by directly enhancing the 
polyadenylation/cleavage process at upstream poly (A) sites. While we cannot formally 
exclude this possibility, several factors suggest otherwise. First, these alleles have 
displayed a number of effects on elongation and are known to be involved in elongation. 
Second, in vitro evidence has shown that rpb2-10 causes RNA pol II to pause while rpb2- 
7 had no effect (Powell and Reines 1996). Similarly, rpb2-10 can strongly decrease full- 
length lacZ RNA formation and enhance defective ADH2 poly (A) site usage whereas 
rpb2-7 had no effect in our experiments. Although rpb2-7 did reduce RNA14, CBPI and 
AEP2 full-length RNA formation to a limited extent, rpb2-10 again displayed much 
stronger effects. In addition, while SPT5 has been indicated to play a role in transcription 
initiation, elongation, and mRNA capping (Swanson and Winston 1992, Swanson et al 
1991, Wada et al 1998, Hartzog et al 1998; Yamaguchi et al 1999, Pei and Shuman 
2002), it has not been identified as affecting polyadenylation/cleavage directly. Finally, 
known defects in poly (A) cleavage/adenylation factors reduce poly (A) site utilization 
and have not been shown to enhance upstream poly (A) site use as presented herein. 
However, in mammalian systems, alternations in the activity or abundance of the 64 kDa 
subunit of CstF polyadenylation factor can in some circumstances influence poly (A) site 
choice (Edwalds-Gilbert et al., 1997). It remains possible therefore that the rpb2-10, spt5-
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4, and dstl defects could exert indirect effects on the activities of poly (A) 
cleavage/adenylation factors.
Many genes with alternative poly (A) sites have been identified and characterized 
in mammalian cells, yeast and several types of viruses. Differential poly (A) site choice 
of some genes is regulated by development stages or in different tissues in mammalian 
cells (see review by Edwalds-Gilbert et al. 1997). Using EST data, more than 5000 
human and 1000 mouse genes have been identified with two or more poly (A) sites 
(Beaudoing and Gautheret 2001). Therefore, regulation of poly (A) site choice is an 
important method for regulating mRNA levels in different cellular environments. The 
results presented herein indicate that the elongation process, through effects on 
transcriptional pausing or arrest, may also regulate mRNA levels by affecting poly (A) 
site choice. Since the same mRNA with different poly (A) site ends can display vastly 
different deadenylation rates and mRNA stabilities, altering poly (A) site choice could 
greatly influence protein translation and abundance in the cell. In addition, more than 
1000 yeast genes could contain internal poly (A) sites (Graber et al 2002). It is obvious, 
therefore, that the proper regulation of pausing/arrest in vivo will be extremely important 
to maintaining both formation and fidelity of full-length mRNA.
Not only do our results confirm an in vivo connection between transcription 
elongation and polyadenylation/cleavage, but also they provide a method to examine 
transcriptional elongation in vivo. The amplified utilization of internal poly (A) sites that 
occurs as a result of defects in elongation factors can be used to develop appropriate 
genetic assays for identifying novel elongation factors, elucidating their mechanisms in
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transcriptional elongation, and for analyzing the types of DNA sites that affect 
transcriptional elongation in vivo.
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CHAPTER n
SPT5 AFFECTS RATE OF mRNA DEGRADATION THROUGH PHYSICAL 
INTERACTION WITH AND INHIBITION OF CCR4 DEADENYLASE ACTIVITY
Introduction
The levels of eucaryotic mRNA can be regulated at many steps, from its initial 
synthesis to its eventual degradation in the cytoplasm. Regulation of the rate o f mRNA 
decay is an important control point in determining the abundance of cellular mRNA. The 
mature mRNA bears a 5’ cap structure and 3’ poly (A) tail that protect the mRNA from 
degradation. A principal mRNA-decay pathway in eucaryotic cells is initiated by 
shortening of the poly (A) tail at the 3’ end (deadenylation) which is then followed by 
removal of the 5’ cap structure (decapping) and subsequent 5’ to 3’ exonuclease digestion 
(Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlradetal., 1994; Muhlradetal., 
1995; Muhlrad and Parker, 1992).
Deadenylation is a key rate-limiting step in the decay of mRNA in that it is the 
initial step for mRNA degradation and the mRNA deadenylation rate can directly affect 
the overall mRNA turnover rate (Cao and Parker, 2001; Couttet et al., 1997; Decker and 
Parker, 1993; Muhlrad et al., 1994; Muhlrad et al., 1995). It has also been shown that the 
poly (A) tail is capable of stimulating the translation of mRNA (Sachs et al., 1997; Wells 
et al., 1998) and inhibiting decapping in an elF4E-independent manner (Wilusz et al., 
2001). Therefore, understanding the mechanism by which mRNA deadenylation occurs
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and its regulation is very important for our understanding of the regulation of mRNA and 
protein levels.
In yeast, the evolutionarily conserved CCR4 protein, as part of the CCR4-NOT 
complex, has been identified as the major cytoplasmic deadenylase (Chen et al., 2002; 
Tucker et al., 2002; Tucker et al., 2001). While PAN2/PAN3, as poly (A) nuclease 
processes the poly (A) tails of mRNA in the nucleus (Brown and Sachs, 1998; Brown et 
al., 1996), CCR4 performs its deadenylase function in the cytoplasm (Tucker et al.,
2001). Biochemical and bioinformatic studies have shown that CCR4 protein contains 
three major functional domains: an N-terminal activation domain that may interact with 
the transcriptional machinery, a central leucine-rich repeat (LRR) domain that binds 
CAF1 and several other putative components of the 1.9 MDaCCR4-NOT complex, and a 
C-terminal exonuclease HI like domain that comprises the apparent CCR4 deadenylase 
function (Chen et al., 2002; Draper et al., 1994; Draper et al., 1995; Liu et al., 2001; Liu 
et al., 1997; Tucker et al., 2002).
The CCR4-NOT complex acts at several junctures in the formation of mRNA.
Not only can the CCR4-NOT proteins, as the cytoplasmic deadenylase complex, act to 
control the degradation of mRNA (Chen et al., 2002; Daugeron et al., 2001; Tucker et al., 
2002; Tucker et al., 2001), these factors also function in repressing the initiation of 
transcription through TFIID contacts (Badarinarayana et al., 2000; Deluen et al., 2002; 
Lemaire and Collart, 2000), in transcriptional elongation (Denis et al., 2001), and in the 
activation of transcription (Denis, 1984; Liu et al., 1998; Sakai et al., 1992). Consistent 
with their multiple functions, the CCR4-NOT proteins have been localized to both 
nuclear and cytoplasmic compartments (Tucker et al., 2002; Tucker et al., 2001).
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Therefore, an important issue is how the regulation of each of these functions occurs at 
the appropriate location and time.
In this study, we identified a physical and functional connection between the 
CCR4-NOT complex and SPT5. SPT5 forms a complex with the SPT4 protein (Hartzog 
et al., 1998), called DSIF in mammalian cells (Wada et al., 1998a). SPT5/SPT4, like 
CCR4-NOT complex, is conserved throughout eukaryotes and has been found to be 
involved in multiple steps o f mRNA processing. SPT5/SPT4 works in conjunction with 
both the positive transcription elongation factor b (P-TEFb) and RNA pol II to control 
transcriptional elongation (Hartzog et al., 1998; Kim et al., 1999; Yamaguchi et al., 
1999b). SPT5/SPT4 has also been found to interact with the mRNA capping enzyme and 
cap methyltransferase. Moreover, SPT5/SPT4 defects lead to accumulation of unspliced 
pre-mRNA (Lindstrom et al., 2003; Wen and Shatkin, 1999). These indicate a role for 
SPT5/SPT4 in pre-mRNA processing. Relatedly, in Drosophila, SPT5 has been found to 
associate with RNA processing exosome (Andrulis et al., 2002).
Yueh-Chin Chiang has reported that immunoprecipitation of SPT5 co- 
immunoprecipites multiple CCR4-NOT components and that in vitro, purified CAF1, and 
the CCR4-C-terminus can each bind purified SPT5. We subsequently determined that 
several spt5 alleles and an spt4 deletion can reduce the degradation rate of ADH2 and 
GAL1 mRNA, and that the same alleles can decrease GAL1 mRNA deadenylation rate. 
While the majority o f SPT5 localizes to the nucleus, some SPT5 is present in the 
cytoplasm. Finally, we showed that SPT5 can inhibit CCR4 deadenylase activity in vitro. 
These observations indicate that SPT5 can affect mRNA degradation through its
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interaction with and inhibition of CCR4 deadenylase activity. These data also imply that 
SPT5 may be important in regulating CCR4 deadenylase activity in the nucleus.
Materials and Methods 
Yeast Strains And Growth Conditions
Yeast strains are listed in Table 1. Strains containing spt5 or spt4 alleles are all 
isogenic to FY1642 (wild-type) except as indicated (Hartzog et al., 1998). Yeast were 
grown on YEP medium (1% yeast extract/2% bactopeptone), minimal medium or CAA- 
U  medium (Liu et al 1998) supplemented with an appropriate carbon source as indicated 
in the Figures. The plasmid pCAFl is YEpl3-CAFl-U whose LEU2 gene has been 
converted to URA3.
Immunofluorescence Assay
The localization of Flag-Tagged SPT5 in the cells was determined by indirect 
fluorescent immunostaining. FY1639 and FY1642 were grown to midlog stage and 
analyzed by standard methods using anti-Flag antibody at a dilution of 1:200 and FITC- 
conjugated goat anti-mouse IgG at 1:400 dilution.
RNA Analysis
Quantitative SI nuclease protection assays were conducted as described (Collart 
and Struhl, 1993). Control experiments in each case indicated that at the concentration of 
SI nuclease used, no radioactively labeled oligonucleotide remained if no RNA was 
present and that the SI nuclease assay was linear over the concentration of RNAs used. 
Total RNA were purified as described previously (Cook and Denis, 1993; Denis et al.,
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1983). Oligonucleotides were radiolabelled at their 5’ end with T4 polynucleotide kinase 
as described (Chen et al., 2002).
The polyadenylated species of GAL1 and MFA2pG mRNA were analyzed by 
using transcriptional pulse-chase and RNase H assay as described previously (Decker and 
Parker, 1993; Muhlrad and Parker, 1992). A 18-nt DNA probe (5’- 
GCCATTTGGGCCCCCTGG-3’) complementary to the sequences 133 bp upstream of 
the GAL1 translation stop codon was hybridized to total yeast RNA prior to RNase H 
cleavage (Muhlrad and Parker, 1992). The resultant GAL1 3’ polyadenylated species 
were detected by Northern analysis using a probe that was complementary to the 3’ end 
of GAL1 (5’-
GCCCAATGCTGGTTTAGAGACGATGATAGCATTTTCTAGCTCAGCATCAGTGA 
TCTTAGGG-3’)- MFA2pG transcript was detected directly by Northern analysis using a 
probe as described previously (Decker and Parker, 1993).
Results
sptS-4. sptS-194 And spt4 Deletion Can Reduce the Rate of mRNA Degradation.
As SPT5 specifically interacts with the C-terminal region of CCR4 that comprises 
the CCR4 deadenylase function (Chen et al., 2002) and with CAF1, we hypothesized that 
SPT5 might be regulating the rate of mRNA degradation through its contacts to CCR4- 
NOT components. We subsequently examined the effect of several spt5 alleles and an 
spt4 deletion on the rate o f ADH2 mRNA decay. CCR4 has been shown previously to 
affect ADH2 mRNA degradation rate (Chen et al., 2002).
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We observed that ADH2 mRNA was stabilized approximately 2- to 3-fold in spt5- 
194, spt5-4, and spt4 deletion strain backgrounds as compared to wild type (Figure 10).
In the same strain background, a ccr4 deletion also resulted in a 2.5-fold stabilization of 
ADH2 mRNA. Combining ccr4 with spt5-4, spt5-194, or spt4 did not further slow the 
rate o f ADH2 mRNA degradation. In contrast, in spt5-25 and spt5-242 strain 
backgrounds, the rate of ADH2 mRNA decay was not affected (Figure 10, left panel), 
ccr4, however, in combination with spt5-242 or spt5-25 still decreased the rate o f ADH2 
mRNA degradation by 2-fold (data not shown). We also observed that spt5-4, like ccr4, 
slowed the rate of GAL1 mRNA degradation by two-fold whereas spt5-242 did not (data 
not shown). These results indicate that certain alleles of spt5 or deletion of spt4 result in a 
slowing mRNA decay. The observation that effect of ccr4 and these spt5/spt4 alleles on 
mRNA degradation is not additive suggests that CCR4 and SPT5/SPT4 are functioning in 
the same pathway in regards to mRNA degradation.
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Figure 10. spt5 and spt4 alleles affect ADH2 mRNA degradation rate.
Wild-type and mutant strains (see Table 1) were pregrown on YEP medium containing 
2% ethanol prior to shifting to medium containing 4% glucose at zero time and the taking 
of RNA samples at the times indicated. The ADH2 mRNA levels were determined by an 
SI nuclease protection assay using probe corresponding to sequences 1126 bp 
downstream of HheADH2 translation start codon (5’-
GGCATACTTGATAATGAAAACTATAAATCGTAAAGACATAAG-3’). The ACT1 
RNA was used to standardize loadings for RNA samples at the different time points 
indicated. ACT1 probe is complementary to the sequences 1039 bp downstream of the 
ACT1 translation start codon (5’-CCACTTTCGTCGTATTCTTGTTTTGAGATCCAC 
ATTTGTTGGAAGGTAGTCAAAGAAGC-3 ’).
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SPTS And SPT4 Mutations Affect mRNA Deadenvlation But Not Decapping
The effect of SPT5/SPT4 on mRNA degradation could be occurring by altering 
the rate of deadenylation, decapping or 5’ to 3’ degradation of RNA transcript (Beelman 
and Parker, 1995). A simple test to determine whether defects in mRNA decay occurs at 
the decapping or later step is to analyze the production of degradation products of the 
MFA2pG RNA relative to the total level of MFA2pG present (Tharun and Parker, 1999). 
MFA2pG gene contains a poly (G) tract insertion in the 3 ’ UTR, which inhibit 
exonuclease activity (Decker and Parker, 1993). Therefore, a poly (G) to 3’ end RNA 
fragment will accumulate when the decapped mRNA is degraded from the 5’ to 
3’direction. However, in the absence of any decapping and 5’ to 3’ mRNA digestion, the 
formation of the poly (G) to 3’ end RNA fragment will be blocked. As shown in Figure 
5 A, like ccr4 (Figure 11 A, lane 3), spt5-4 has no obvious effect on the formation o f poly 
(G) to 3’ end mRNA fragment (Figure 11A, lane 2 compared to lane 1). Since these 
results indicate that the spt5/spt4 alleles are not affecting decapping or subsequent 5’ 
RNA degradation, we tested whether these alleles affected the rate of mRNA 
deadenylation, the same step that CCR4 and CAF1 control. Changes in the mRNA 
deadenylation rate was followed using a transcriptional pulse chase analysis (Decker and 
Parker, 1993) with the GAL1 mRNA. Expression of GAL1 was rapidly induced for 15 
minutes by adding galactose to raffinose growth culture and then repressed by adding 
glucose. The deadenylation of this pool of newly synthesized GAL1 mRNA was 
monitored at different time points by Northern analysis.
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Figure 11. spt5 and spt4 alleles affect mRNA deadenylation but not decapping
(A). Wild-type (FY1642), spt5-4 (FY1668-uH), and ccr4 (FY1642-la) strains containing 
plasmid RP??? were grown in CAA-LT medium with 4% glucose to midlog stage. Total 
RNA was extracted after shifting to 2% galactose for 4 hours. MFA2pG transcripts were 
detected by using transcriptional pulse-chase assay (Decker and Parker, 1993). The upper 
band represents the full-length MFA2pG transcript and the lower band corresponds to the 
poly (G) to 3’ end RNA fragment.
(B). Wild-type (FY1642), spt5-4 (FYI668-11H), spt5-242 (FY1635), and spt4 (GHY180) 
strains were shifted from raffinose-containing YEP medium to galactose-containing YEP 
medium for 15 minutes to induce GAL1 gene expression. After transcriptional repression 
by the addition o f glucose, total RNA were extracted at different time point as indicated 
and RNase H digestion was conducted and Northern analysis was used to detect the 
GAL1 specific mRNA.
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Table 4 deadenylation rate of GAL1 
mRNA in wild-type, spt5, and spt4 strains






As shown in Figure 1 IB, we observed that, in a wild-type strain, the poly (A) tail 
is degraded to an oligo (A) tail length of approximately 8-13 A’s by around 10-15 
minutes, followed by slow deadenylation of the oligo (A) tail. It has been shown 
previously that decapping and 5’ to 3’ degradation of the transcript occurs once the oligo 
(A) tail form appears (Couttet et al., 1997; Decker and Parker, 1993; Muhlrad et al., 
1994). The rate of GAL1 mRNA deadenylation was found to about 2.9 A’s per minute. 
Similarly in the spt5-242 strain which had no effect on ADH2 or GAL1 mRNA decay 
rate, the poly (A) tail was shortened at a rate of approximately 3.3 nucleotides per 
minutes (Table 4), with a portion of GAL1 mRNA with oligo (A) tail observed also in 10 
to 15 minutes (Figure 1 IB, left panel). In contrast, in spt5-4 and spt4 deletion strains, 
deadenylation rate of GAL1 mRNA was calculated to be about 2.1 nucleotides per 
minutes (Table 4), and the oligo (A) tail form of GAL1 mRNA routinely appeared in 20 
to 25 minutes (Figure 5B, right panel).It should be noted that the total RNA intensity 
decreased after about 20 minutes in the wild-type and spt5-242 strain (Figure 1 IB, left 
panel). However, we did not see an obvious reduction in the intensity of the GAL1 
mRNA even after 40 minutes in spt5-4 and spt4 deletion strain (Figure 1 IB, right panel), 
supporting the view that the deadenylation, decapping, and 5’ to 3’ mRNA digestion of
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the GAL1 mRNA was significantly delayed in spt5-4 and spt4 background because of the 
slower rate of deadenylation. These observations indicate that the deadenylation rate of 
GALJ mRNA can be reduced by spt5-4 and spt4 but not by spt5-242 and that SPT5/SPT4 
affects mRNA turnover through their effects on mRNA deadenylation.
SPT5 is Present in The Cytoplasm
The above experiments indicated a role for SPT5 in mRNA turnover. Previous 
research has shown that SPT5/SPT4 play a role in RNA metabolism that occurs in the 
nucleus (Hartzog et al., 1998; Lindstrom et al., 2003; Pei and Shuman, 2002; Swanson et 
al., 1991a; Wada et al., 1998a; Wen and Shatkin, 1999; Wu-Baer et al., 1998). CCR4- 
NOT components, in contrast, are found in both nuclear and cytoplasmic compartments 
(Tucker et al., 2002; Tucker et al., 2001) and the primary function of CCR4 in mRNA 
degradation is presumed to be cytoplasmic. If SPT5 is involved in mRNA degradation 
through its interaction with CCR4-NOT components, it might be expected that some 
SPT5 should be present in the cytoplasm. To reexamine the subcellular localization of 
SPT5, we used a strain with a Flag tag on the C-terminus of the chromosomal SPT5 gene, 
and an immunofluorescence assay was conducted using a FITC-conjugated secondary 
antibody. As shown in Figure 12, the majority of SPT5 is localized to the nucleus, 
consistent with previous observations. Careful analysis of the data indicates, however, 
that some SPT5 is present in the cytoplasm (Figure 12). These results support the 
hypothesis that SPT5 is involved in mRNA degradation through its interaction in the 
cytoplasm with CCR4. These data do not exclude the possible role that SPT5 may still 
regulate CCR4 deadenylase activity in the nucleus, especially as CCR4 has been shown
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to play roles in transcriptional initiation and elongation (Badarinarayana et al., 2000; 




Figure 12. SPT5 is localized to both the nucleus and the cytoplasm.
Strains expressing Flag-Tagged SPT5 (FY1642) and wild-type control (FY1639) were 
incubated with anti-Flag antibody and stained with FITC-conjugated anti-mouse antibody 
and DAPI as indicated.
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Discussion
The SPT4/SPT5 complex has been shown to be important in multiple steps of 
mRNA processing (Hartzog et al., 1998; Lindstrom et al., 2003; Pei and Shuman, 2002; 
Swanson et al., 1991a; Wen and Shatkin, 1999; Wu-Baer et al., 1998; Yamaguchi et al., 
1999b). We show herein that this complex in yeast physically associates in vivo with 
components of the CCR4-NOT complex. The CCR4-NOT complex, in turn, has known 
or suggested roles in transcriptional initiation, elongation, and mRNA degradation (Chen 
et al., 2002; Daugeron et al., 2001; Denis, 1984; Denis et al., 2001; Tucker et al., 2002; 
Tucker et al., 2001; Viswanathan et al., 2003). Several pieces o f evidence provided by 
Yueh-Chin Chiang support a close physical association o f SPT5 with components of the 
CCR4-NOT complex. First, in the two-hybrid assay SPT5 displayed interactions with 
CCR4-NOT complex components NOT1, NOT2, CCR4, CAF40, and CAF130. Second, 
each of these two-hybrid interactions was shown to occur by co-immunoprecipitation 
analysis. Third, SPT5 and CCR4, at their physiological concentration, were found to 
specifically co-immunoprecipitate. Fourth, the CAF1 protein when overexpressed 
interfered with SPT5-CCR4 interactions. Moreover, deleting CAF1 revealed additional 
SPT5 contacts to the CCR4-NOT components, NOT1, NOT4, and CAF40 when they 
were expressed at their physiological concentrations. These results clearly indicate a 
close proximity in the cell of CCR4-NOT components with SPT5. This physical 
proximity agrees with various experiments establishing that the components of CCR4- 
NOT complex and SPT5 protein can be present both in the nucleus and in the cytoplasm 
(Collart and Struhl, 1993; Swanson et al., 1991a; Tucker et al., 2002; Tucker et al., 2001).
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In addition to the physical interaction between CCR4-NOT proteins and SPT5, 
several pieces of evidence also suggest that SPT5 functionally interacts with CCR4-NOT 
complex. First, genetic assay showed that spt5-4, spt5-25, spt5-8, and spt5-194 were 
found to suppress defects in ccr4 (C. L. Denis, pers. Comm.). Second, spt5-4, spt5-194, 
and spt4 can slow down mRNA degradation rate. These alleles when combined with 
ccr4, however, did not further reduce the rate of mRNA decay. Third, these alleles which 
slow down mRNA decay also reduced the rate o f mRNA deadenylation but had no effect 
on mRNA decapping and 5’ to 3’ digestion. The sptS alleles that did not affect mRNA 
decay, however, also had no effect on mRNA deadenylation. Fourth, SPT5 is also present 
in the cytoplasm. Finally, in vitro deadenylase activity assay showed that SPT5 can 
partially inhibit CCR4 deadenylase activity but SPT5 alone does not have deadenylase 
activity.
It should be noted that the spt5-4 and spt5-194 proteins are defective for binding 
SPT4 (G. Hartzog, pers. Comm.). Other spt5 alleles not defective for binding SPT4, such 
as spt5-242 or spt5-25, has no effect on mRNA degradation and deadenylation, indicating 
that SPT5/SPT4 interaction is important in its effect on mRNA degradation and 
deadenylation. There are two models explaining how SPT5/SPT4 could affect the mRNA 
deadenylation rate. First, the interaction between SPT4 and SPT5 can interfere with the 
negative effect o f SPT5 on CCR4 deadenylase activity. Therefore, after the SPT5/SPT4 
complex is disrupted either by mutating the SPTS gene (spt5-4, and sptS-194) or by 
deleting the SPT4 gene, SPT5 will be released to inhibit CCR4 deadenylase activity. 
Another model is that the SPT5/SPT4 interaction can affect SPT5 localization. SPT4 may 
retain SPT5 in the nucleus by binding SPT5. Disrupting interaction between SPT5 and
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SPT4 will result in more SPT5 present in the cytoplasm, and therefore, result in inhibition 
of CCR4 deadenylase activity. We observed that SPT4 is more predominantly localized 
in the nucleus as compared to SPT5. However, deleting SPT4 did not appear to affect the 
subcellular localization of SPT5 (data not shown).
Although spt5-4, spt5-194 and spt4 can reduce the rate of GAL1 mRNA 
deadenylation, these effects are not as significant as that observed with ccr4. In addition, 
these alleles did not display as prominent defect the deadenylation end point as did ccr4 
and cafl strains (Figure 11 A; Tucker et al., 2001). Since these spt5 alleles and spt4 have 
similar effect on reducing the rate of mRNA degradation as ccr4 did, but less effects on 
mRNA deadenylation, SPT5/SPT4 might also be affecting mRNA degradation through 
other mechanisms. The requirement of deadenylation before decapping indicates that the 
poly (A) tail also acts as an inhibitor o f decapping(Decker and Parker, 1993; Muhlrad et 
al., 1994; Muhlrad et al., 1995). Several observations suggest that the ability o f the poly
(A) tail to inhibit decapping is mediated through the poly (A) binding protein (PAB1) 
(Caponigro and Parker, 1995; Morrissey et al., 1999; Sachs et al., 1987). ccr4 can affect 
not only the rate of deadenylation, but also the extent of deadenylation, therefore 
inhibiting the subsequent decapping and 5’ to 3’ deadenylation (Tucker et al., 2001). We 
observed that, in spt5-4 and spt4 strains, the poly (A) tail is degraded to an oligo (A) tail 
length of approximately 6-10A’s by around 20-25 minutes, whereas obvious GAL1 
mRNA intensity reduction was not observed even after 40 minutes (Figure 5B, right 
panel). This observation indicates that spt5-4 and spt4 not only slow the rate of 
deadenylation, but they might also block the poly (A) tail mediated decapping signal.
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ccr4 Enhances the Ability of RNA pol II to Form the Full-length lacZ  mRNA
Genetic analyses have implicated the CCR4-NOT complex in playing possible 
roles in transcription elongation (Denis et al 2001). To investigate whether CCR4 
affected elongation in vivo, an SI nuclease protection assay was employed to analyze the 
ability of RNA pol II to form full-length lacZ mRNA in presence of a ccr4 deletion. We 
found, as shown in Figure 13, that in contract to other elongation factor defects, ccr4 
displayed enhanced full-length lacZ 3' RNA formation (one and a half to two-fold effects 
for ccr4, Figure 13A, lanes 1 and 2, and Figure 13B, lanes 1 and 2). A cafl deletion gave 
similar results to ccr4 (Figure 13 A, lane 3).
To determine whether ccr4 affects RNA pol II transcript through lacZ gene by 
affecting cryptic poly (A) sites usage within lacZ gene, both total RNA and poly (A)
RNA were used to conduct SI nuclease protection assay (Figure 13B). My results 
showed that a ccr4 deletion displayed similar effects on full-length lacZ RNA formation 
when both total and poly (A) RNA were used (1.9-fold effects for total RNA, Figure 13B, 
lanes 1 and 2; 1.8-fold effects for poly (A) RNA, Figure 13B, lanes 3 and 4). This result 
suggested that the ccr4 deletion may enhance the ability of RNA pol II to form full- 
length lacZ RNA by affecting lacZ cryptic poly (A) sites usage.
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Figure 13
4
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Figure 13. ccr4 and cafl alleles enhance full-length lacZ mRNA formation.
(A) SI nuclease protection analysis of total RNA extracted from the WT strain EGY188 
(lane 1), ccr4 strain EGY188-la (lane 2) and cafl strain EGY188-cl (lane 3). SI 
nuclease protection assays, growth conditions, and calculations were conducted as 
described in Figure 1.
(B) Both total RNA (lane 1 and 2) and poly (A) RNA (lane 3 and 4) were extracted from 
WT strain EGY188 (lane 1 and 3) and ccr4 strain EGY188-la (lane 2 and 4) and used for 
SI nuclease protection assays. SI nuclease protection assays, growth conditions, and 
calculations were conducted as described in Figure 1.
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ccr4 Does Not Enhance the Ability of RNA pol II to Form Full-length lacZ RNA By
Suppressing Transcriptional Termination/cleavage.
ccr4 may affect lacZ cryptic poly (A) sites usage directly or indirectly. It can 
indirectly reduce cryptic poly (A) site usage through its effect on elongation. It can also 
reduce cryptic poly (A) site usage by suppressing transcription termination/cleavage. To 
determine which possibility is the case, the effect of ccr4 on transcriptional 
termination/cleavage was examined. SI nuclease protection assays were carried out in 
strains carrying plasmid pGCYCl which expresses Gall-CYCl. Probes against the CYC1 
coding region (+139) and against a site that was 350 bp downstream of the CYC1 
polyadenylation site (+853) were used to examine the abundance of the different CYC1 
transcript species. In the wild-type strain, the normal CYC1 polyadenylation site (+503) 
was used and no CYC1 transcript beyond +853 was detected (Figure 14, lanes 1,5 and 8). 
With rnal4  and rnalS mutations which can affect transcription termination (Birse et al 
1998), normal transcription termination was suppressed and more long CYC1 transcripts 
beyond +853 were formed after switching growth from the permissive (25°C, Figure 14, 
lanes 6 and 7) to the restrictive condition (37°C, Figure 14, lanes 3 and 4). The papl 
mutation, which has no effect on transcription termination (Figure 14, lane 2), and the 
ccr4 deletion can not suppress transcription termination (Figure 14, lane 9). These results 
suggest that ccr4 does not enhance the ability of RNA pol II to form full-length lacZ 
RNA by suppressing transcriptional termination.
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Figure 14




Figure 14. ccr4 does not suppress transcriptional termination of the CYC1 gene.
SI nuclease protection analysis of total RNA extracted from WT strain W303 (lane 1 and
5) and EGY188 (lane 8),pap 1-5 strain LM98 (lane 2), rnal4-l strain LM91 (lane 3 and
6), rnal5-l strain LM88 (lane 4 and 7) and ccr4 strain EGY188-la (lane 9) containing 
plasmid pGCYCl which expresses Gal-CYCl. For lanes 1 to 7, strains were pregrown in 
4% glucose medium at 25°C for 20 hr, and then shifted to 2% galactose/2% raffmose at 
nonpermissive temperature (37°C) for 4 hr (lanes 1 to 4) or at permissive temperature 
(25°C) for 4 hr (lanes 5-7). For lanes 8 and 9, strains were pregrown in 4% glucose 
medium at 30°C for 20 hr, and then shifted to 2% galactose/2% raffmose at 30°C for 4 hr. 
Probe 1 is directed against the CYC1 coding region (+139) and probe 2 is directed against 
a region 350 bp downstream of the CYC1 polyadenylation site (+853).
:i0 m
1 2 3 4 5 6 7 8 9
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The Effect of ccr4 on full-length lacZ mRNA Formation Is Not Due To Increased
mRNA 3' End Degradation.
Since both CCR4 and CAF1 have been shown to be part of the cytoplasmic 
mRNA deadenylase complex (Tucker et al 2001), it was possible that the above effects 
on full-length lacZ 3’ RNA formation were resulting from differential effects on the 
degradation of the 3’ and 5’ ends o f lacZ mRNA. To address this possibility we utilized 
the GALl-lacZ reporter to determine the rate o f degradation of the 5' and 3' ends of the 
lacZ mRNA following the shutting off of GALl-lacZ transcription by growth on glucose- 
containing medium. As expected, ccr4 decreased the degradation rates of lacZ mRNA by 
2- to 3-fold (Figure 15,6 min. half life for WT and 16 min. half life for ccr4), but it did 
so for both 5’ and 3’ ends of the lacZ mRNA (Figure 15). These results indicate that the 
enhanced ability to form full-length lacZ mRNA by ccr4 results from an enhanced ability 
to elongate through the lacZ gene.
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Figure 15
wild-type ccr4A





Figure 15. ccr4 decreases lacZ mRNA decay rate but does not decrease degradation of 
the 3' end of the lacZ mRNA relative to that of the 5' end.
Wild-type and ccr4 strains (see Table 1) transformed with the GALl-lacZ plasmid were 
pregrown on 2% galactose/2% raffmose prior to shifting to medium containing 4% 
glucose at zero time and taking of RNA samples at the times indicated. The 5' lacZ probe 
corresponded to sequences 0.5 kb downstream of the initiation site whereas the 3' lacZ 
probe was located 2.9 kb downstream. Hie ACT! RNA was used to standardize loadings 
for RNA samples at the different time points indicated.
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While rvb2-4 And rpb2-10 Alleles Can Suppress a ccr4 Defect ccr4 And spt5-4 Have
a Mixed Effect On Transcription Elongation.
To further investigate the role of CCR4 on transcription elongation, we examined 
the effect of ccr4 on lacZ mRNA elongation in rpb2 and sptS backgrounds.
As previously shown, rpb2-4, rpb2-10 and spt5-4 reduced the ability o f RNA pol 
II to form full-length lacZ RNA (Figure 16, lanes 2 ,3  and 9) while ccr4 increased it 
(Figure 16, lane 4 and 8). While ccr4 caused a 2.2-fold increase in full-length lacZ 
mRNA (Figure 16, lane 4 compared to lane 1), it allowed only 1.4- and 1.6-fold effect, 
respectively, in full-length lacZ mRNA formation in rpb2-4 and rpb2-10 backgrounds 
(Figure 16, lanes 5 and 6 compared to lanes 2 and 3). This result indicates that rpb2-4 and 
rpb2-10 alleles can partially suppress the effect of ccr4 on lacZ elongation and that CCR4 
acts upstream of RPB2 to affect elongation. In contrast, the ccr4 allele, while causing a 
1.7-fold increase in full-length lacZ formation in a wild-type background (Figure 16 lane 
8 compared to lane7), caused a 3.8-fold increase in an spt5-4 background (Figure 16, lane 
10 compared to lane 9). In addition, spt5-4 still has an effect on lacZ elongation in the 
ccr4 background (Figure 16, lane 10 compared to lane 8), although not as much as it does 
in wild-type background (Figure 16, lane 9 compared to lane 7). This mixed effect of 
ccr4 and spt5-4 alleles on lacZ elongation indicates that CCR4 may act downstream or in 
conjunction with SPT5 to affect elongation.
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Figure 16
3':5' 1.0 2.2 0.59 0.85 0.49 0.77 1.0 1.7 0.38 1.3
lanes 1 2 3 4 5 6 7  8 9 10
Figure 16. ccr4 specifically suppresses the spt5-4 defect on elongation but not that of 
rpb2-4 or rpb2-10.
SI nuclease protection analysis of total RNA extracted from ccr4 strain Z96-la (lane2), 
rpb2-4 strain Z100 (lane 3), rpb2-4 ccr4 strain ZlOO-la (lane4), rpb2-10 strain Z106 
(lane 5), rpb2-10 ccr4 strain Z106-la (lane 6) and the isogenic WT strain Z96 (lanelO), 
ccr4 strain FY1642-la (lane 8), spt5-4 strain FY1668-uH (lane 9), spt5-4 ccr4 strain 
FY1668-uH-la (lane 10) and die isogenic WT strain FY1642 (lane 7). SI nuclease 
protection assays, growth conditions, and calculations were conducted as described in 
Figure 1.
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Growth Condition of the Yeast Strain can Affect Full-length Formation of the lacZ
RNA.
Several spt5 alleles have been shown to be cold sensitive (Hartzog et al., 1998). It 
has also been shown that an Artificial Arrest (ARTAR) site does not appear to function 
under optimal growth condition (Kulish and Struhl, 2001). These data indicate that the 
growth condition o f the cells might affect RNA pol II transcript through the genes. 
Therefore, the effect of different growth conditions on full-length lacZ mRNA formation 
was examined in wild-type and elongation defective strains background. The yeast were 
grown in the medium containing 4% glucose, 2% galactose/raffinose, 2% ethanol, or 4% 
glucose with 200ug/ml 6-azauracil respectively. In the wild-type strain background, as 
shown in Figure 17, less optimal growth condition (galactose/raffinose or ethanol) can 
increase full-length lacZ RNA formation (Figure 17A, lanes 2,3, compared to lane 1; 
17B, lane 2, compared to lane 1), but the drug 6-AU has no effect on full-length lacZ 
RNA formation. In contrast, in the spt5-4 strain background, although the ability of RNA 
pol II to form full-length lacZ RNA was decreased compared to wild-type, the growth 
conditions have no significant effect on full-length lacZ formation (Figure 17A, lanes 5 to 
8). The exact same result was obtained in an rpb2-4 strain background (Figure 17B, lanes 
3 and 4).
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Figure 17
WT spt5-4
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Figure 17. The effect of the growth 
condition of cells on full-length lacZ RNA 
formation
SI nuclease protection analysis of total 
RNA extracted from spt5-4 strain FY1668- 
uH (A, lanes 5 to 8) and the isogenic WT 
strain FY1642 (A, lanes 1 to 4); rpb2-4 
strain Z100 (B, lanes 3 and 4) and the 
isogenic WT strain Z96 (B, lanes 1 and 2). 
The strains were pregrown over night in the 
medium containing 4% glucose prior to 
shifting to growth condition as indicated in 
the Figure for 4 hours. SI nuclease 
protection assays and calculations were 
conducted as described in Figure 1.
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Degradation Results 
SPT5 Can Affect MFA2dG RNA Decay
We showed in Chapter II that SPT5 can affect the degradation rate o f ADH2 and 
GAL1 mRNA probably through its physical and functional interaction with CCR4. The 
effect of CCR4 on MFA2pG RNA degradation has been thoroughly investigated 
previously (Tucker et al., 2001). To further confirm the functional connection between 
CCR4 and SPT5, the effect of SPT5 on MFA2pG RNA decay was examined.
I examined the decay rate of MFA2pG RNA in wild-type and spt5-4 strain 
backgrounds. MFA2pG is under the control of GAL1 promoter, allowing the measure of 
its decay rate by adding glucose to repress transcription. I observed that the MFA2pG 
RNA was stabilized about 2-fold in the spt5-4 strain compared to wild-type (Figure 18). 
spt5-4 also reduced the degradation rate of ADH2 and GAL1 mRNA as shown in Chapter 
II, indicating that SPT5 is required for the turnover of a number of yeast mRNA.
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Figure 18
WT sptS-4
O' 2' S' 10' 20' O' 2' 5' 10' 20'
Figure 18. spt5-4 can reduce the decay rate of the MFA2pG mRNA.
Transcriptional shutoff analysis of MFA2pG mRNA from wild-type (FY1642) and spt5-4 
(FY1668-uH) strains. The full-length (FL) mRNA and decay fragment (Frag.) are 
indicated at die left. Time points are minutes after the addition of glucose.
SPT5/SPT4. Similar As CCR4/CAF1. Can Affect the Endpoint of MFA2dG mRNA 
Deadenylation
It has been shown previously that not only can CCR4, as major cytoplasmic 
deadenylase, affect MFA2pG mRNA deadenylation rate, it also affect the length of poly 
(A) tail o f MFA2pG mRNA at late time point (Tucker et al., 2001). Therefore, to 
understand the relationship between CCR4 and SPT5, the effect of SPT5/SPT4 on the 
endpoint of MFA2pG mRNA deadenylation was examined.
The distribution of poly (A) tail length was measured for MFA2pG under steady 
state conditions from wild-type, ccr4A, sptS and spt4 alleles. As shown in Figure 19, if 
samples were first treated with RNase H and oligo (dT), the poly (A) tail of MFA2pG
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mRNA from different strains will be removed. The remaining transcripts have the same 
length (Figure 19, lanes 1 to 6). Wild-type MFA2pG mRNA has a steady state poly (A) 
distribution from 75 to about 10-12 adenosine residues (Figure 19, lane 7; Tucker et al.,
2001). In ccr4A strain, MFA2pG mRNA has the longest poly (A) tail (Figure 19, lane 8). 
spt5-242 allele, which has no effect on ADH2 mRNA degradation and GAL1 mRNA 
deadenylation, did not affect on poly (A) distribution (Figure 19, lane 9). In contrast, in 
the spt5-4, spt5-194, and spt4A strains, in which ADH2 mRNA decay rate and GAL1 
mRNA deadenylation rate were reduced, the poly (A) tail of MFA2pG is slightly longer 
than observed in wild-type strain, but is shorter than observed in ccr4A strain (Figure 19, 
lanes 10 to 12, compared to lanes 6 and 7).
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Figure 19
MFA2pG
Figure 19. SPT5 and SPT4 can affect MFA2pG mRNA deadenylation endpoint.
The deadenylation end point for MFA2pG transcript was measured in the wild type 
(FY1642), ccr4A (FY1642-la), spt5-242 (FY1635), spt5-4 (FY1668-uH), spt4A 
(GHY180), and spt5-194 (FY300) strains. The strains were pregrown over night in the 
medium containing 4% glucose prior to shifting to 2% galactose for 4 hours. Steady state 
mRNA were detected by Northern analysis with or without removal of poly (A) tails with 
RNase H and oligo (dT) as indicated in the Figure.
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GENERAL DISCUSSION
The Regulation of Gene Expression Is a Continuous Process
Gene expression is a pathway with multiple steps. The regulation of gene 
expression can occur at each step during this process. The different steps in this pathway 
have previously been treated and studied as independent events. In recent years, a 
growing number of genetic studies have revealed functional links between the protein 
factors that carry out the different steps in the gene expression pathway. Many factors 
have also been found to perform their regulatory function in more than one steps in this 
process. SPT5 has been identified as a protein that can regulate transcriptional initiation, 
elongation, and pre-mRNA processing (Andrulis et al., 2002; Hartzog et al., 1998; Kim et 
al., 1999; Lindstrom et al., 2003; Wen and Shatkin, 1999; Yamaguchi et al., 1999b). In 
Chapter I, we further confirmed the role o f SPT5 in the regulation of transcriptional 
elongation. In addition, out results in Chapter II also suggested that SPT5 can regulate 
gene expression by affecting mRNA stability, possiblely through its physical and 
functional interaction with CCR4-NOT complex,confirming multiple roles for SPT5 in 
the regulation of gene expression. Similarly, the CCR4-NOT complex acts at several 
steps in the gene expression pathway, including transcriptional initiation, elongation, and 
mRNA degradation (Badarinarayana et al., 2000; Chen et al., 2002; Daugeron et al.,
2001; Deluen et al., 2002; Denis, 1984; Denis et al., 2001; Lemaire and Collart, 2000;
Liu et al., 1998; Sakai et al., 1992; Tucker et al., 2002; Tucker et al., 2001). In Chapter 
m , we further confirmed that CCR4 can affect transcriptional elongation in vivo.
86
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Moreover, rpb2 mutations can suppress this effect. Combined with the data that CCR4 
can associate with RNA pol II (Chang et al., 1999), these results suggest that CCR4 
might affect transcriptional elongation through its interaction with RNA pol n.
It has also been shown that the regulation of one step of gene expression can 
subsequently affect another one or more steps o f this process. For example, pre-mRNA 
splicing can promote transcription elongation and is required for efficient export o f the 
resulting mRNA in to the cytoplasm (Reed and Hurt, 2002). In Chapter I, we also showed 
that increased pausing can enhance upstream poly (A) site utilization, indicating a 
connection between transcriptional termination/cleavage and elongation. Moreover, 
elongation defects can increase upstream poly (A) site choice at 3’ end of GAL1, and 
therefore, enhance shorter but more stable GAL1 mRNA formation, suggesting a 
connection between the transcriptional elongation and termination/cleavage which 
happened in the nucleus and the mRNA degradation in the cytoplasm.
SPTS Needs SPT4 To Perform Its Function
Recent studies have demonstrated roles for SPT5 and SPT4, as a complex, in the 
regulation o f transcriptional elongation both in yeast and in humans (Hartzog et al., 1998; 
Kim et al., 1999; Wada et al., 1998; Yamaguchi et al., 1999a; Yamaguchi et al., 1999c). 
Although it has been shown that an spt4 deletion has similar phenotypes as some spt5 
defects (Hartzog et al., 1998) and SPT4 has a positive role in transcriptional elongation 
(Rondon et al., 2003), SPT5 has been shown to contact with the RNA pol II and is 
thought to play the major role in regulation of transcriptional elongation. The importance 
of SPT4 in this process is not clear. In Chapter I, we examined the effect of some spt5
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alleles and spt4 deletion on the full-length lacZ RNA formation. It was shown that spt5-4 
and spt4 deletion can reduce full-length lacZ RNA formation. Interestingly, the spt5-4 
protein is defective for binding SPT4 (G. Hartzog, pers. comm.), indicating that SPT5 
requires SPT4 to play a role in transcriptional elongation. In addition, we also showed in 
Chapter II that the spt5-4, spt5-194, and spt4 alleles slowed the rate of degradation of 
ADH2 mRNA and the rate of deadenylation of GAL1 mRNA. spt5-194 proteins is also 
defective for binding SPT4 (G. Hartzog, pers. comm.). Other spt5 alleles not defective for 
binding SPT4 had no effect on ADH2 mRNA degradation and GAL1 mRNA 
deadenylation. These results suggest that the interaction between SPT5 and SPT4 is also 
required for their roles in regulation of mRNA degradation. Therefore, SPT4 is 
indispensable for SPT5 to perform its function in the regulation of gene expression.
The Interaction Between The CCR4-NOT Complex And The SPT5/SPT4 Complex 
Can Affect Their Roles In The Regulation of Gene Expression 
Our lab showed that SPT5 can interact with CCR4-NOT complex and inhibit 
CCR4 deadenylase activity. While CCR4 is present everywhere in the cell, most of SPT5 
is localized to the nucleus. Therefore, an important function o f SPT5 might be to inhibit 
CCR4 deadenylase activity in the nucleus so that the mature mRNA in the nucleus will 
not be deadenylated before export to the cytoplasm and translate into protein. Both CCR4 
and SPT5 have been shown to bind with the RNA Pol IICTD (Chang et al., 1999; 
Lindstrom and Hartzog, 2001) and we also showed in Chapter IE that CCR4 and SPT5 
have a mixed effect on full-length lacZ RNA formation, indicating that SPT5 can affect 
the function o f CCR4 in regulation of transcriptional elongation and inhibit the CCR4
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deadenylase activity in nucleus. CCR4, in turn, can also affect the function of SPT5 in 
transcription.
Chromatin immunoprecipitation assay showed that SPT5 can associate with both 
promoters and open reading frames of transcribed genes in vivo (Pokholok et al., 2002). 
SPT5/SPT4 has also been found to interact with the mRNA capping enzyme and cap 
methyltransferase (Lindstrom et al., 2003; Wen and Shatkin, 1999). Moreover, SPT5 has 
been found to associate with RNA processing exosome in the nucleus (Andrulis et al.,
2002). It might be possible that SPT5 associates with RNA directly or by binding with 
other RNA binding proteins in the nucleus and is exported to the cytoplasm together with 
mature RNA. Therefore, the stability of mRNA can be regulated by SPT5 through its 
interaction with and inhibition of CCR4 deadenylase activity.
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